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As one of the body’s largest environmental interfaces, the skin is routinely
exposed to a myriad of inflammatory stimuli. It functions as a barrier acting as the first
line of defense against pathogens, while simultaneously protecting the organism from
dehydration. Maintaining an intact barrier is therefore paramount to organismal
survival, and the foremost torchbearers of this task are skin epithelial stem cells
(EpSCs). EpSCs reside in the basal layer of the skin, survive long-term, and are
capable of both self-renewing and differentiating into multiple skin lineages. To
efficaciously maintain the barrier, EpSCs must be able to sense and respond to
environmental cues. Here, I unearth an adaptive mechanism whereby EpSCs retain
an epigenetic memory of prior inflammatory exposure that endows them with
enhanced sensitivity and responsiveness to subsequent tissue damage. During
secondary injury, inflammatory memory is mediated by cytosolic dsDNA sensor and
activator of the inflammasome AIM2, and its downstream effectors caspase-1 and
interleukin-1.

Characterization

of

the

chromatin

landscape

in

inflammation-experienced EpSCs reveals specific retention of monomethylation of
histone 3 on lysine 4 in memory chromatin domains primed for reactivation.
Altogether, this body of work identifies a novel mechanism by which EpSCs cope
with and adapt to environmental stress in preparation for the next inflammatory
trigger.
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CHAPTER 1

INTRODUCTION

1.1

Inflammatory Skin Disease

The skin can be subdivided into two compartments: the epidermis and the dermis. The epidermis is the outermost layer that creates a sealed barrier to the external
environment and is separated from the underlying dermis by a thin fibrous basement
membrane. The epidermis is populated by skin cells called keratinocytes, which stratify into multiple layers including the stratum basale (innermost), stratum spinosum,
stratus granulosum, and stratum corneum (outermost) to ensure formation of a protective barrier. These keratinocytes reside in a complex niche replete with a diverse
network of cellular members that are in constant communication to ensure healthy tissue regulation and maintenance of the barrier. One of the most important cell types
in the skin niche are immune cells, which are present in the skin to sample different antigens, alert the body to pathogen invasion, and serve as rapid responders in
orchestrating tissue repair after injury. The crosstalk between keratinocytes and immune cells is a fine-tuned balance, where any dysregulation can lead to the formation
of inflammatory skin disorders.
One of the most common skin inflammatory diseases is psoriasis, which affects
approximately 2% of the population [1]. It is a remitting and relapsing chronic disease,
where skin lesions reoccur in the same body sites over and over again. These skin
lesions are caused by hyperproliferative keratinocytes that fail to produce an effec-
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tive cornified layer leading to a hyperthickened epidermis (acanthosis) and retention
of nuclei in the stratum corneum (parakeratosis) [2]. These lesions are hypervascularized leading to their red color and are hyperennervated making the skin region
more sensitive to pain. Psoriasis is associated with a large immune cell infiltrate in
the dermis consisting of dendritic cells, macrophages, neutrophils, and T cells with
a concurrent elevation of T cells in the epidermis. While there is a large immune
component to psoriasis, it remains unclear whether this disease is epithelial or immunological in nature. What we do know is the importance of the crosstalk between
immune cells and keratinocytes.
Infiltrating immune cells create an inflammatory microenvironment rich in cytokines
that fuel keratinocyte proliferation including type I interferons, TNF-α, IL-17, and IL22 [2] [3]. Stimulated keratinocytes in turn secrete chemokines such as CXCL8,
CXL10, and CCL20 that recruit immune cells to the lesion [4]. Keratinocytes themselves propagate the inflammatory milieu by secreting cytokines such as IL-1β, IL-6,
and TNF-a that induce the proliferation of neighboring keratinocytes [5]. A recently
appreciated component of psoriatic pathogenesis is the detection of abundant levels
of cytosolic self-DNA within skin lesions. Aberrant cytosolic DNA is a danger signal, which keratinocytes respond to via activation of the AIM2 inflammasome which
leads to processing and release of IL-1β [6]. Cytosolic DNA can also complex with
keratinocyte-derived antimicrobial cathelicidin peptide LL-37, which activates dendritic cells via TLR9 providing a potential mechanism by which cytosolic self-DNA
functions as a pro-inflammatory danger associated molecular pattern leading to a
break in immunologic tolerance thereby contributing to the chronic nature of psoriasis [7].
At present there is no cure for psoriasis, and a paucity of efficacious therapies
to offer patients. Therapies can be broken into multiple classes including: biologics
(must be injected or via IV), oral treatments, phototherapy (i.e. regular exposure to
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UV light), or topicals (i.e. corticosteroids). Each of these classes has major drawbacks, take for example prolonged exposure to UV light increasing the risk of skin
cancer. The most commonly used treatment for psoriasis, which has not responded
to other treatments, is biologics. Biologics aim to do one of two things: directly target
and block T cells or block their proinflammatory cytokines (TNFa, IL-17a, IL-12, and
IL-23) [8] [9]. Because these therapies are injected or taken via IV, they have deleterious systemic side effects such as an increased risk of infection, inflammatory bowel
disease, or new/worsening heart failure to name a few. What the current biologics
and therapies all have in common is that they aim to target the immune system, but
as discussed before the origins of psoriatic pathogenesis remain unknown. With the
need for more efficient therapies, there is a need to consider psoriatic pathogensis
from an epithelial angle.
One of the most curious and perplexing aspects of psoriasis is that the lesions
relapse in the same body site. Recent work highlights that skin in different body locations can be replete with distinct populations of commensal microbiota, which affect
the immune cell milieu [10]. In fact, the skin on the back of a person’s elbow is more
similar to another person’s elbow than to their own palms or other body site [11]. One
can imagine this having an effect on the propensity for the disease to develop in common body sites between patients. Nevertheless, the skin itself is still fundamentally
the same from one body site to another, and offers a tremendous opportunity to gain
insight into how psoriatic pathogenesis affects skin biology. To begin there are some
outstanding questions that need be addressed such as: what are the long-term consequences of inflammation on keratinocytes and how do these keratinocytes cope
with and adapt to inflammatory stress? Answering these questions will offer insights
into psoriatic pathogenesis that one day can be used for the development of a novel
therapeutic intervention.
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1.2

The skin is maintained in health and disease by epithelial stem cells

Adult tissue stem cells in the skin reside in the hair follicle, sebaceous gland,
and the epidermis [12] [13] [14]. Basal interfollicular epidermal stem cells (EpSCs)
reside in one single layer that adheres to the basement membrane, which is rich in
extracellular matrix and growth factors. The main role of EpSCs is to continuously
replenish the skin during homeostasis and re-epithelialize the skin barrier after tissue
injury. They accomplish this role through their ability to both self-renew, giving rise
to ‘sister’ stem cells, and to execute a terminal differentiation program that gives rise
to the outer layers of the skin including the spinous, granular, and corneum layers
[15] [16]. When a basal cell commits to terminally differentiate, it goes through major
transcriptional and morphological changes that results in an enucleated cell at the
stratum corneum later, which eventually gets sloughed off. The progression from
basal cell to sloughing takes approximately 4 weeks in humans, and in mice, the
minimum transit time from basal layer to cornified layer is about 1-2 weeks [17] [18].
EpSCs are retained long-term, and individual clones can remain in the basal layer for
over 50 weeks in mice [19] [20] [17].
Following tissue injury such as a full thickness wound where both the epidermal
and dermal layers of skin are removed, EpSCs are activated and begin to proliferate.
Stem cells near the wound edge coordinate their behavior by balancing proliferation,
differentiation, and migration to re-epithelialize the breached barrier. EpSCs become
highly proliferative, and begin to directionally divide towards the wound edge while
simultaneously conducting collective migration, which leads to an elongated epithelial tongue that extends into the wound bed until the barrier is sealed [21] [22]. The
balance between EpSCs’ wound healing response and homeostasis is carefully regulated, and when this balance is disturbed there is an increased propensity for tissue
dysregulation that could result in the development of dysfunctional tissue states such
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as hyperproliferative inflammatory skin disorders, non-healing wounds, or squamous
cell carcinoma [23] [22] [24].

1.3

Stem cells modulate their behavior upon detection of environmental cues

1.3.1

Stem cells during infection and inflammation

Adult stem cells are importantly tasked with maintaining their tissues both in health
and disease. This function is made possible by their ability to sense and respond
to various environmental cues. Stem cells (SCs) express a number of membranebound receptors that enable them to identify changes or danger in their extracellular
environment such as cytokine and pattern recognition receptors. Similar SCs express cytoplasmic sentinels to alert them to foreign material within the cell. Each of
these sensors is upstream of well-defined pathways that influence stem cell behavior.
These pathways result in decisions between quiescence and activation, self-renewal
and differentiation, metabolic state, and lineage bias. These sensors are expressed
and active during both homeostasis and disease, and are critical to enabling stem
cells to adequately maintain their tissue.
In the skin, EpSCs express a variety of cytokines and chemokines that enable
them to identify cues and initiate reactionary transcriptional programs. One example, EpSC bound epidermal growth factor receptor (EGFR), plays a crucial role in
regulating innate immune cell-driven inflammation, maintaining barrier function, and
contributing to antimicrobial defense [25] [26]. If EGFR signaling is inhibited or impaired, the result is an uncontrolled inflammatory cascade with a huge immune cell
surge, the production of a multitude of proinflammatory cytokines, and increased susceptibility to infection. Hair follicle stem cells (HFSCs), whose primary task is to fuel
hair regrowth, reside in the bulge niche, which is an orifice to the external environment and provides a potential entry point for external pathogens. HFSCs can sense
junctional perturbations in their niche that disturb barrier function, and quickly coor5

dinate a transcriptional response that results in direct signaling and recruitment of
immune cells via secretion of CCL2. HFSCs begin to proliferate, but rather than exit
their niche which is their homeostatic response to proliferation, they remain in the
bulge to contain the breach and reinforce the barrier [27].
Aging impacts the ability of skin EpSCs to be as sensitive to environmental signals as their younger selves. Aged mice have significantly delayed wound healing
and barrier restoration, as the EpSCs are less capable of interpreting signals and
upregulating the necessary transcriptional response. Specifically, the inefficient upregulation of Skints and phosphorylation of STAT3 results in the inability to activate
and maintain dendritic epidermal T cells (DETCs), which promote re-epithelialization
after injury [22].
Looking broadly to other adult stem cell compartments provides additional insight
into the capability and mechanisms by which SCs sense and respond to environmental cues. Hematopoietic stem cells (HSCs) reside in the bone marrow and give
rise to both myeloid and lymphoid lineages of immune cells. During a bacterial or
viral infection, HSCs are activated in what is known as emergency hematopoiesis
to replenish innate immune cells. This process involves a biased lineage decision
towards myelopoiesis, since T cells are capable of proliferating in response to infection. HSCs must therefore detect an infection, interpret the inflammatory cues,
and generate myeloid cells. One mechanism by which emergency hematopoiesis is
regulated is through IFNγ secretion by cytotoxic CD8+ T cells, which induces mesenchymal stromal cells (resident bone marrow niche cells) to release IL-6. Multipotent
hematopoietic stem and progenitor cells (HSPCs) in turn sense IL-6, resulting in the
reduced expression of transcription factors Runx1 and Cebpa, which are important to
progenitor self-renewal. IL6-induced downregulation of Runx1 and Cebpa in myeloid
progenitors leads to increased differentiation, and the production of more myeloid
cells enabling efficacious control of the infection [28].
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Additionally, HSPCs can directly detect infection via membrane-bound toll like receptors (TLR) that recognize specific pathogen associated molecular patterns (PAMPs).
HSPCs express TLR4, which recognizes LPS, a paradigmatic gram-negative bacterial product. LPS-induced TLR4 signaling results in emergency hematopoiesis via
stem cell activation, cytokine production, and myeloid differentiation [29]. HSCs also
express cytoplasmic sensors such as NLRP1, which recognizes intracellular PAMPs,
and leads to inflammasome formation. Activation of the inflammasome leads to HSC
pyroptosis and the release of IL-1β, which alerts neighboring cells of an infection so
they can act to neutralize the threat. Activation of these pathways must be tightly regulated, as prolonged stimulation can lead to impaired HSC self-renewal and reduced
competitive repopulation activity [30].
The response of HSPCs to infection is mosaic due to their heterogeneous expression of Il6ra and Tlr4. Within the broad population of HSPCs, there are multiple
subtypes including long-term-HSCs, short-term-HSCs, multipotent progenitors, and
lymphoid-primed multipotent progenitors. Single cell proteomics highlights a dynamic
communication between these HSPC sub-populations in response to the sensing of
danger signals. Varied receptor expression between sub-populations leads to distinct
activation patterns and cytokine profiles based on the class of infection or signal received. This dynamic communication and heterogeneous cytokine release leads to
an efficient and robust immune response with rapid myeloid cell recovery [31].
Intestinal epithelial stem cells (ISCs) also directly respond to changes in their microenvironment. During inflammation, direct sensing of tissue resident innate lymphoid cell (ILC)-derived IL-22 promotes ISC proliferation through the activation of the
STAT3 pathway. STAT3 activation is important to ISC maintenance and ISC production of innate antimicrobial molecules REG3b and REG3g [32]. Crosstalk between
immune cells and ISCs is therefore imperative to survival and maintenance of intestinal tissues during inflammation.
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1.3.2

Stem cells during homeostasis

Beyond foreign infections, adult stem cells are equipped to respond to cues from
their homeostatic microenvironment. In HSCs, multiple cytokine receptor families
converge and rely on JAK1 to relay critical information from the extracellular space to
HSCs to modulate their behavior. JAK1 has been implicated in different immunological and neoplastic diseases and is important in normal cytokine production and autocrine feedback. Without JAK1, in homeostasis, HSCs lack the ability to self-renew
and bias their differentiation to towards the myeloid lineage. Transcriptional analysis
of Jak1 deficient HSCs reveals that STAT1, STAT2, and IFN-regulated transcription
factors, which are activated dowstream of JAK1 signaling, inadequately transcribe
their target genes. Failure to link JAK1 signaling to transcriptional ouput results in
HSC inability to sense hematopoeitc stress and regulate hematopoiesis [33].
Intestinal epithelial stem cells (ISCs) residing in the crypt exist in a symbiotic relationship with commensal gut microbiota. These gut microbiota help to protect the
host from pathogenic microorganisms, and communicate with ISCs through the release of microbe-associated molecular patterns (MAMP). ISCs sense the presence
of MAMPs through TLR4 and NOD2, which is an intracellular innate immune sensor.
When NOD2 is activated by its ligand muramyldipeptide, a peptidoglycan motif, downstream signaling promotes stem cell survival [34]. This ISC adaptation is handy both
during routine tissue regeneration, but also during pathogenic infections that require
stem cell survival and tissue repair.
ISCs also communicate with different subsets of T cells through their expression
of MHCII, which influences their decision between differentiation and self-renewal.
Helper T cells promote ISC differentiation through secretion of IFNγ, IL-17A, or IL-13,
and Tregs promote ISC self-renewal via IL-10 [35]. Lastly, ISC sensing of ILC and
γδT cell derived IL-22 was found to contribute to ISC homeostasis through regulation
of the DNA damage response. ILCs and γδT cell sense genotoxic compounds in
8

the diet and secrete IL-22, which induces ISCs to initiate a protective response that
preserves their and their progeny’s genomic integrity [36].
All together these studies highlight the importance of adult tissue stem cells in being able to sense and respond to various environmental cues. Whether by membranebound receptors, cytosolic sentinels, or direct cell-cell contact, stem cells have evolved
to efficiently react to changes in their microenvironment that enable them to effectively
maintain tissue integrity both in health and disease.

1.4

Stem cell intrinsic immunity

Intrinsic immunity is a cellular defense mechanism, whereby cells routinely produce defense proteins and cytosolic sentinels to stand guard and detect pathogen
invasion. Intrinsic immunity enables tissue stem cells to evade infections from viruses
and pathogens, to regulate the delicate balance between their activation and quiescence, as well as to avoid detection from the adaptive immune system.
Adult stem cells representing each of the three multipotent germ layers including
neural, pancreatic, and mesenchymal stem cells express at baseline Interferon Stimulated Genes (ISGs) despite being refractory to interferon. The intrinsic expression
of these genes protects stem cells from viral infection; however, upon terminal differentiation these genes are downregulated making downstream progeny more susceptible to reduced interferon signaling and infection. Dynamic regulation of chromatin
modifications including H3K4me3 and H3K27ac at ISG-associated loci correlates to
ISG expression as stem cells differentiate. Loss of ISG expression from the IFTM
gene family in stem cells make them susceptible to a myriad of viral infections, including respiratory viruses, flaviviruses and zoonotic virus, leading to their inability to
regenerate their respective tissues. While distinct tissue stem cells express cell-typespecific groups of ISGs, the role of ISGs in endowing intrinsic immunity to stem cells
is conserved [37].
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An additional mechanism cells utilize to sense viral infection is through cytosolic sensors that detect ds/ssDNA. Mesenchymal stem cells (MSCs) detect infection
of murine gammaherpesvirus through cytosolic dsDNA sensor cGAS. The cGASSTING pathway is imperative for the induction of ISGs and protection against viral
infection and replication in MSCs [38]. dsDNA sensors also have inflammasomeindependent mechanisms to regulate cellular adaptation to environmental signals.
Canonically when AIM2 senses dsDNA, it activates the cell to respond by binding
ASC resulting in cleavage of pro-CASP1 and downstream release of proinflammatory cytokines IL-1β and IL-18 orchestrating the host’s defense to pathogen infection.
However, recent work in intestinal stem cells, highlights that AIM2 also plays a dual
role by functioning as a negative regulator of cell proliferation. In AIM2 deficient
mice there is increased proliferation of ISCs due to enhanced susceptibility of these
cells to aberrant Wnt-signaling, elevated phosphorylation of AKT, and expression of
c-Myc [39]. These studies highlight the overarching role that cytosolic sensors play in
protecting tissue stem cells from infection and maintaining homeostasis.
Tissue stem cells can be immune privileged and are capable of avoiding detection
from the innate and adaptive immune system. Stem cells that remain in a quiescent
state and are slow cycling, such as HFSCs and satellite cells, evade T-cell detection
by downregulating antigen presentation machinery, such as MHCI. This protects their
integrity and allows them to evade T-cell mediated cell death. Notably, faster cycling
stem cells that are responsible for continuous tissue maintenance such as intestinal,
ovary, and mammary stem cells express antigen presenting machinery and are thus
able to be detected and targeted for T-cell mediated clearance [40].
We can glean insight into intrinsic immune proteins from the transcriptional and
chromatin landscapes of stem cells at baseline and following tissue injury. This information can elucidate the preparedness of a stem cell to rapidly respond to injury, the
type of response the cell can mount, and identify if there are long term or persisting
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changes that would affect cell behavior.

1.5

Dynamic regulation of chromatin landscape enables cellular training

Gene expression patterns within a cell are controlled by the epigenome, which is a
complex network of chromatin and histone modifications that cooperate to stimulate
or repress gene activity. These modifications exist in a cell-type specific manner,
conferring cell-type identity. Importantly, however, these marks are dynamic allowing
for changes in transcriptional output to exact a shift from homeostasis to an injured
state. Understanding these marks, their influence on gene expression, and their
regulatory mechanisms will provide mechanistic insight into a stem cell’s response to
inflammation.
Chromatin exists in either active or repressed states, the latter of which leads to
gene silencing. Chromatin repression can occur through several mechanisms including DNA methylation and histone modifications [41]. DNA methylation most commonly occurs through 5-methylcytosine (5mC), which is transferred to DNA via DNA
methyltransferases (DNMTs). This mark is commonly found in CpG islands, and
when enriched at promoters, the associated gene is repressed via the prevention
of positive transcription factor binding or the promotion of negative regulators [42].
This mark is readily passed on to daughter cells after cell division via the function
of DNMTs. Importantly, however, this mark is reversible and through the TET enzyme catalyzed oxidation of 5mc to 5-hydroxymethylcytosine (5-hmc), DNA can be
demethylated. Histone methylation on certain residues such as H3 Lysine 9 (K9) and
H3 Lysine 27 (K27) also leads to gene repression [43]. Histone lysines are methylated via lysine methyltransferases (KMTs), and specific lysine residues often have
their own KMT [44]. For instance, G9a methylates H3K9me2, Polycomb methylates
H3K27me3. In the case of histone modifications, methylation is not always silencing,
such as in the case of methylation of H3 lysine 4 (K4), which results in gene acti-
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vation. Like DNA methylation, histone methylation is also reversible and can be dynamically changed. Methyl groups can be removed by histone demethylases such as
Jumonji-domain containing proteins (JMJC) or lysine-specific histone demethylases
(LSD) [44].
Euchromatin is considered active or open, and enables binding of transcriptional
machinery to drive gene expression. The predominant histone modification that
marks active chromatin is lysine acetylation. Lysines are acetylated via histone
acetyltransferases (HATs)
The chromatin landscape of non-coding regions of DNA, specifically cis-regulatory
elements such as promoters and enhancers, elucidates how transcription of the associated gene is regulated [43]. Active promoters are marked by H3K4me3. H3K4me3
recruits chromatin remodeling factors such as CHD1 and BPTF, which open chromatin making it permissive to transcription [45] [46]. Simultaneously, H3K4me3 prevents the binding of repressive complexes such as NuRD and INHAT [47] [48]. H3K4me3
is also a good example of the integration of the histone code and DNA methylation
status, where H3K4me3 blocks the binding of the DNMT3, which is capable of binding unmodified H3K4, preventing methylation/ repression of the promoter. Repressive
histone marks such as H3K27me3 can also be found at promoters, which functions
to shut transcription down.
Enhancers are cis regulatory elements that can be upstream, downstream, intronic, proximal or distal and act to increase transcription of their associated genes
[49] [50]. Enhancers can exist in multiple states including inactive, poised, primed,
and active. Inactive enhancers are often methylated and have histone marks such as
H3K9me2 indicating a heterochromatic closed state. Active enhancers are marked
by H3K27ac [51]. Often when an enhancer is decommissioned meaning the associated gene is no longer actively transcribed, it will lose its H3K27ac mark but retain
H3K4me1 indicating it is primed. Primed enhancers are also typically marked by
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5mC hypomethylation or the hydroxylated version, 5hmC. Poised enhancers contain
the primed H3K4me1 mark, but also acquire H3K27me3 suggesting a more inactive
state. Often H3K4me1 at distal enhancers will precede H3K27ac, and the mechanism by which methyltransferase such as MLL1/2 is initially recruited to these regions
remains an open question [52]. One leading hypothesis is that cell-type specific or
signaling dependent transcription factors interact with KMTs and guide them to these
regions [53].
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CHAPTER 2

INFLAMMATORY MEMORY SENSITIZES SKIN EPITHELIAL STEM CELLS TO
TISSUE DAMAGE

2.1

Introduction

The skin is an epithelial barrier that functions as the body’s first line of defense
against environmental assaults, and as such is especially vulnerable to a range of
pathogens and noxious agents. Maintaining the skin as an intact barrier is the key
function of long-lived epithelial stem cells (EpSCs), which reside in in the innermost
(basal) layer of the skin epithelium. These EpSCs can both self-renew and execute
a terminal differentiation program that generates a continuous upward flux of barrier
cells. Signals emanating from the basement membrane and underlying dermal niche
constituents, facilitate EpSC function by inducing molecular programs that maintain
EpSC identity and lineage commitment. EpSCs additionally sense and respond to
cues from their microenvironment that signal danger, resulting in initiation of programs
aimed at recruiting immune cells and reinforcing barrier integrity.
To this end, recent studies have identified a fine-tuned crosstalk between EpSCs and immune cells as critical to efficacious tissue repair [22]. Resident immune
cells aid to alert EpSCs to danger, inducing them to initiate repair programs involving proliferation, migration, and recruitment of additional immune cells to the site of
injury [27] [22]. EpSC proliferation and migration in tissue repair are carefully regulated, and when this process goes unchecked there is an increased propensity for
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tissue dysregulation resulting in the development of dysfunctional tissue states such
as hyperproliferative inflammatory skin disorders or tumorigenesis. Considering the
vulnerability of EpSCs to inflammatory pressures, neither their involvement in the
primary response to inflammation nor the enduring consequences are well understood. To address these open questions, I chose a well-characterized model of acute
Imiquimod-induced skin inflammation to assess the long-lasting consequences of inflammation on EpSCs.

2.2

Results

2.2.1

Imiquimod is a self-resolving model of acute skin inflammation

Imiquimod (IMQ) is a Toll Like Receptor (TLR) 7/8 and NALP3 ligand that is applied as a topical cream to the back skin of mice for six consecutive days, where it
induces a robust inflammatory response [54] [55] [25]. Skin resident sentinel dendritic cells sense IMQ and migrate to lymph nodes where they secrete IL-23 to induce
the expansion of RORC+ γδ T cells and Th17 cells. These activated lymphocytes
travel back to the skin secreting IL-17 and IL-22 among other pro-inflammatory cytokines that are directly sensed by EpSCs inducing their hyperproliferation (Figure
2.1 A). In agreement with prior reports, after six days of treatment there is a psoriaticlike pathology characterized by epidermal hyperthickening, parakeratosis, hypervascularization, hyperinnervation, immune cell infiltrate, aberrant STAT3 signaling, and
apoptosis [55] (Figure 2.1 B).
Importantly, IMQ-induced inflammation self-resolves after cessation of treatment,
whereby day 30 all notable perturbations subsided and the skin’s homeostatic architecture was restored (Figure 2.1 B, C). Given these self-resolving features, we
wondered whether inflammation-sensitized stem cells and/or their progeny contribute
to epidermal homeostasis after resolution of inflammation.
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Figure 2.1: Imiquimod is a self-resolving model of skin inflammation A Mechanism for
imiquimod (IMQ)-induced skin inflammation. B Schematic depicting timeline of Control (Ctrl) or IMQ treatment with corresponding histopathology and epidermal thickness quantifications. n= 3. C Immunofluorescence images and corresponding quantifications of EDU+ epidermal (IFE) and HF (bulge) basal cells at D6 of IMQ or Ctrl
treatment and at D30 following treatment. n=3. DAPI, 4’6-diamidino-2-phenylindole.
2.2.2

Lineage tracing skin stem cells in inflammation

To track SC dynamics during and after inflammation, we utilized inducible-marker
based fate mapping to delineate in vivo cellular behavior (Figure 2.2) [16]. Specifically, we crossed Rosa-LSL-YFP reporter mice that contain the Cre recombinaseoestrogen receptor fusion protein (CreER) driven by keratin (Krt) promoters active
in either EpSCs (Krt14) or their transient progeny (Krt10). Krt14 is present in all
skin EpSCs, and at low doses of tamoxifen, Krt14-CreER preferentially labels EpSCs of the interfollicular epidermis (and infundibulum). By contrast, Krt10-CreER is
expressed in differentiating layers. Since hair follicle SCs (HFSCs) can transiently
contribute to wound-repair, we also tested Krt19-CreER, specific to the HF bulge SC
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niche [56] [57].
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Figure 2.2: Lineage tracing strategy for skin stem cells. Tamoxifen (TAM)-induced
RosaYFP reporter lineage tracing with Krt14CreER, expressed by Krt14+ EpSCs; Krt10CreER, expressed by Krt10+ terminally differentiating epidermis; and
Krt19CreER, expressed by Krt24+ HFSCs. n=4. Arrows mark YFP+ keratinocytes.
Two days after administering tamoxifen, YFP+ cells co-localized with Krt14 in the
basal layer (Krt14-CreER), Krt10 in the suprabasal layer (Krt10-CreER), or Krt24 in
the HF bulge (Krt24-CreER) [58] [17] (Figure 2.2 and Figure 2.3 A-C). When IMQ
was subsequently administered to the skin of Krt14-CreER;Rosa-LSL-YFP mice and
then lineage-traced, YFP+ cells persisted in the IMQ-treated skin at equivalent numbers to naive (vehicle control) skin for up to 180 days post-inflammation (Figure 2.3
D). Because Cre recombinase was not activated without tamoxifen, the YFP+ EpSCs were long-lived and had survived the inflammatory assault. By contrast, Krt10CreER-activated YFP+ cells (although initially present) were shed within six days,
indicating that once progenitors commit to terminal differentiation, they do not revert
even in response to IMQ (Figure 2.3 B, E). Lastly, characteristic of their stemness
Krt19-CreER-activated YFP+ HFSCs persisted and were detected in the bulge niche
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30 days after inflammation (Figure 2.3 C, E). However, they did not contribute to the
epidermal pathology that typified the IMQ inflammatory response. These results led
us hereafter to focus on Krt14+ EpSCs.
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2.2.3

Enhanced wound healing after inflammation

The persistence of inflammation-experienced EpSCs long after epidermal homeostasis had been restored led us to wonder whether this assault may have had a lasting effect on them and/or their microenvironment. To address this question, we challenged inflammation-recovered skin with a secondary assault, in this case wounding
(Figure 2.4 A). Notably, post-inflamed mice closed their wounds approximately 2.5
times faster than naive control mice (Figure 2.4 B, C). The enhanced wound-healing
response exhibited by inflammation-experienced skin was observed even when the
initial assault had occurred 180 days earlier (Figure 2.4 D).
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Figure 2.4: Epidermal wound repair post-inflammation. A Schematic of wound healing experiment timeline. B Images of wound healing in skin 30 days post-inflammation
(PI) versus control (Ctrl). Scale bars = 2mm. C Accelerated wound healing in day 30
PI skin: Left plots area of wound over time and right plots the rate constant K of
wound closure using one-phase decay model (n=17; ***P-value¡0.0001).D Accelerated wound healing observed 180 days after inflammation; graph plots rate constant
K of wound closure using a one-phase decay model (n=5; ***P-value=0.0003). Data
are mean ±s.e.m. n denotes the number of biologically independent animals. Experiments replicated twice and significance determined by two-tailed t-test (95% confidence). NS, not significant (P>0.05).
To determine whether this heightened sensitivity could be elicited broadly by different primary skin irritants that provoke robust epidermal hyperproliferation, we replaced IMQ with various other treatments such as topical application of vitamin D
analogue calcipotriol (MC903, to model atopic dermatitis); topical application of 12O-tetradecanoylphorbol 13-acetate (TPA; to induce hyperplasia; epidermal abrasion
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wounding; or infection with the fungal pathogen Candida albicans [59] [60] [61] [62].
Following restoration of epidermal homeostasis and skin barrier function, mice were
wounded. In all cases, wounds healed faster in inflammation-experienced skin. These
results highlighted the generality of the response, indicating that once skin is sensitized to inflammation, it reacts faster when faced with a secondary assault (Figure
2.5).
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After a full-thickness wound, re-epithelialization is mediated by sensitized epi-
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dermal EpSCs, which transiently express Krt17. These EpSCs first multiply along
the wound edge and then migrate into the wound bed to repair the skin barrier
breach [22]. Inflammation-experienced skin displayed augmented epidermal thickness and accelerated re-epithelialization, but showed similar rates of proliferation
(Figure 2.6 A-C). Re-epithelialization by the migrating Krt14+ and integrin α5+ epidermal tongue was considerably longer in post-inflamed wounds by day 3, and by
day 5 the post-inflamed wounds were entirely re-epithelialized, a full 2 days faster
than their control counterparts (Figure 2.6 B).
To exclude myofibroblast-mediated dermal contraction as a notable contributor
to the post-inflamed augmented rate of wound closure, we affixed a silicone splint
around the wound leaving re-epithelialization via migrating EpSCs as the sole means
of healing [63]. Without tissue contraction, inflammation-experienced mice still exhibited enhanced re-epithelialization and accelerated wound repair (Figure 2.6 D).
Moreover, using an assay that specifically measures keratinocyte migration, we found
that keratinocyte outgrowth from ex vivo explants was more robust after inflammation
than in controls (Figure 2.6 E) [22]. These findings suggest that inflammation induces long-term changes in EpSCs that enhance their capacity to react swiftly to a
secondary assault.
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2.2.4

IMQ intrinsically sensitizes EpSCs

EpSCs receive cues from their local milieu as well as from infiltrating immune
cells and circulating factors that direct wound repair. We thus sought to evaluate the
relative importance of these secondary effectors on the sensitization of inflammationexperienced skin to wounding. When IMQ was administered to half the dorsal skin,
skin pathology was restricted to direct application sites (Figure 2.7 A). With this observation, we hypothesized that if the post-inflamed accelerated wound healing was
due to systemic (circulating) factors that wounding distal to the site of inflammation
should also result in augmented tissue repair. We thus treated half of the dorsal skin
and wounded the contralateral side, and found that the distal site closed at a rate
comparable to control skin ruling out substantial contribution from systemic factors
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Figure 2.7: Accelerated wound healing occurs only at direct sites of prior inflammation. A Epidermal hyperthickening is confined to the initial site of inflammation
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Wound closure at day 30 is enhanced only at sites of previous IMQ treatment (n=12).
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We next addressed whether the heightened responsiveness of inflammation-experienced
EpSCs was secondarily dependent on the memory of resident innate and adaptive
immune cell populations [64]. CD45+ cells including innate immune cells such as
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Langerhans cells, dermal dendritic cells, macrophages, and eosinophils, and adaptive immune cells such as dendritic epidermal γδ T cells (DETCs, γδ T cell receptor (TCR)high ), returned to baseline levels 30 days after inflammation (Figure 2.8 A,
B). While macrophages returned to basal levels in the skin post-inflammation, we
wanted to rule out contribution of innate immune cell memory. To this end we used
clodronate, which induces apoptosis after being taken up by phagocytic cells (CITATION) and effectively reduced skin-resident macrophage numbers by 90%. We
clodronate-depleted skin-resident macrophages before wounding and found no obvious effect in the wound repair advantage displayed by EpSCs after inflammation
(Figure 2.8 C).
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Figure 2.8: Immune cell populations return to baseline after inflammation.A Flow cytometric analysis and quantification of total immune cells (CD45+ ). B Flow cytometric
analysis and quantification of αβ T cell receptor (TCR) T cells, dermal γδ T cells
(γδTCRlow ), dendritic epidermal T cells (DETC; γδTCRhigh ), Langerhans cells (LC),
dermal dendritic cells (DDC), macrophages (Mac), and eosinophils (Eos) from control and day 30 post-inflamed skins (n≥3). C Clodronate liposome-mediated resident
macrophage depletion before wounding does not alter the wound repair advantage
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veh-ctrl), *P=0.0266 (clodronate). Data are mean ±s.e.m. n denotes the number of
biologically independent animals. Experiments replicated at least twice and significance was determined using a two-tailed t-test (95% confidence).
Next, taking into consideration, that the initial IMQ response is triggered by a specific subset of immune cells, namely γδ T lymphocytes that express the transcription
factor (TF) retinoic acid receptor-related orphan receptor C (RORC), we assessed if
there was a change in the frequency of this subset of immune cells in the skin (Figure
2.9 A) [25]. In contrast to innate immune cells and DETCs, which showed comparable
representation in control and post-inflamed skin, RORC+ adaptive immune cells were
increased in IMQ-treated skin both at the peak of inflammation (5.0 times) and after
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resolution (1.8 times). In agreement with prior reports, these persistent RORC+ cells
were located in close proximity to the epidermis and hair follicles (Figure 2.9 B). To
probe if these lingering RORC+ cells were responsible for accelerated wound healing post-inflammation, we generated a RorcCre;Rosa-iDTR mouse model whereby
RORC+ cells were inducibly depleted after the initial inflammatory response, but prior
to wounding. Delivery of diphtheria toxin (DT) resulted in >90% depletion of RORC+
cells without a compensatory increase in other skin effector T cell populations. Consistent with involvement of tissue-resident T cells in wound and pathogen responses,
depletion of RORC+ cells in post-inflamed and control mice resulted in delayed wound
closure relative to their wild-type counterparts [62] [65]. Importantly, however, even after RORC+ depletion, inflammation-experience skin still exhibited a two-fold increase
in wound closure rate compared to naive control skin (Figure 2.9 C).
To more rigorously establish that the heightened wound healing in inflammationexperienced skin went beyond adaptive immune cell changes, we investigated the
phenomenon in Rag2-null mice, which still mount an inflammatory response to IMQ
despite the absence of T and B cells (Figure 2.9 D). In Rag2-null mice, post-inflamed
skin closed wounds significantly faster than naive skin. These results provide compelling evidence that the augmented tissue repair response exhibited by inflammationexperienced skin occurred independently of an enhanced T cell response (Figure 2.9
E).
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2.2.5

EpSC memory at the chromatin level

A memory of prior exposure to inflammatory stimuli has long been thought to
be a property unique to immune cells. We posited that the heightened responsiveness to tissue damage observed in inflammation-experienced EpSCs may involve
inflammation-induced changes in chromatin dynamics analogous to those recently
described for innate immune memory in macrophages and natural killer cells [66] [67].
To explore this possibility, we purified epidermal EpSCs from IMQ-treated skin at the
peak of inflammation (day 6) and after their return homeostasis (days 30 and 180).
We next employed Assay for Transposase Accessible Chromatin with high-throughput
sequencing (ATAC-seq) [68]. Agnostic to specific types of epigenetic modfications,
this strategy enables global identification of accessible chromatin states.
To purify epidermal EpSCs, we devised a stringent purification strategy based
upon the unique combination of surface markers Sca-1 and integrins α6 and β1, expressed by both post-inflamed and naive EpSCs (Figure 2.10 A). We then employed
fluorescent activated cell sorting (FACS) to purify EpSCs, while excluding CD45 (immune), CD117 (melanocytes), CD140a (fibroblasts), and CD31 (endothelial) skin
cells (Figure 2.10 B). Quantitative PCR (qPCR) confirmed the purity of our EpSCs
(Figure 2.10 C).
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ATAC-Seq was next performed in duplicate on EpSCs at D6 (peak), D30, and
D180 post-inflammation. Independent biological replicates showed strong correlation (R2≥0.97). As expected, ATAC signals were enriched at transcription start sites
(TSS) and binding sites for distal regulatory element CCCTC-binding factor (CTCF)
sites, and were similarly distributed over various genomic and intergenic regions in
all samples (Figure 2.11 A, B). EpSC-specific genes such as Klf5 and Krt14 demon-
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strated similar chromatin accessibility patterns (Figure 2.11 C).

Figure 2.11: ATAC-Seq quality control in EpSCs. A Density plots depicting enrichment of ATAC-seq signals at TSSs ± 3kb and arount CTCF factor-binding sites. The
x axis depicts respective distance ± 1kb from each of these domains. B Distribution
of ATAC-seq peaks with defined genomic regions. UTR, untranslted regions of predicted mRNAs. C Genomic browser shots of peaks enriched in EpSC-specific genes
Klf5 and Krt14 and unaffected by IMQ. Arrows denote direction of transcription.
By contrast, striking differences were seen between D6 IMQ-treated and control
EpSCs. A total of 44,414 unique peaks (31% of total) were identified at the peak
of inflammation [69] (Figure 2.12 A). These open chromatin regions associated with
ontologies that typify inflammatory crosstalk in skin disease and inflammation: JAKSTAT, LPS-mediated, and EGFR signaling. Associated genes were enriched (P10-12 )
in motifs for key epidermal transcription factors (such as AP-1 (Jun, Fos and ATF
members), AP2γ, KLF5, ETS2, GRHL2/3 and p63), as well as factors such as NF-κB
and STAT1/3, the activation of which as been associated with inflammation [70].
By day 30 after IMQ exposure, many peaks had resolved. Notably, however,
more than 2,000 IMQ-induced peaks were maintained, suggestive of an inflammatory memory (Figure 2.12 B). Some peaks were even present at day 180, long after inflammation has resolved (Figure 2.12 A, B). PANTHER pathway analysis of
their associated genes revealed enrichment for inflammation- and hyperproliferationassociated pathways including apoptosis signaling, interleukin signaling, oxidative
stress response, RAS, and PI3 kinase pathways (Figure 2.12 C). Strikingly, these
genomic regions also showed a strong enrichment for stress-associated TF binding
motifs ATF3, AP-1, NRF2, P63, ETS2, CEBPB, ELK3, KLF5, and STAT3. STAT3 was
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notable as it is known to be phosphorylated and activated after IMQ treatment [25].
Although, it was re-activated in the secondary response, STAT3 activity was not maintained during the interim (Figure 2.12 D). Thus, remarkably, many of the IMQ-induced
changes to the EpSC chromosomal landscape were maintained long after resolution
of the initial inflammatory assault and restoration of epidermal homeostasis.
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skin (n=3). n denotes the number of biologically independent animals. Experiments
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2.2.6

Inflammation-sensing chromatin elements

Our data thus far suggests a model, whereby inflammation-activated transcription
factors and other chromatin modifiers facilitate the initial opening of certain chromatin
domains. Both epidermal transcription factors and chromatin modifiers present in
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both inflammatory/stress and/or post-inflamed homeostatic conditions can then bind
maintaining these regions accessible. The model further predicts these accessible
domains retained after resolution of inflammation would serve as accessible platforms
for accelerated re-activation upon a secondary assault (Figure 2.13 A).
Two important facets of this model were tested in this initial publication, and remaining aspects are works in progress. First, we interrogated the ability of the retained post-inflamed chromatin peaks to function as inflammation-sensing elements.
To this end, we cloned individual peaks sustained post-inflammation (associated with
Cotl1, Armc6, Aoah,Aim2) from genomic DNA isolated from inflammation-experienced
EpSCs. The peaks were then cloned into a pLKO vector just before a minimal sv40
promoter followed by the eGFP transgene. The construct also included an internal reporter Pgk-H2B-RFP. This vector was then packaged into a lentivirus (LV), and transfected into 293T cells to produce high titer LV. Using the Fuchs lab well-established in
utero LV delivery system, high titer LV was injected into the amniotic sac of developing embryos at E9.5, when the developing epidermis is one single cell layer (Figure
2.13 B). LV stably transduces only the first cell layer it encounters ensuring that only
epidermal progenitors and their progeny would be infected (Figure 2.13 C). Viral positive cells would stably express H2B-RFP, but eGFP would only be detectable if the
peaks cloned into the vector were capable of driving gene expression.
Mice were aged to P21, where H2B-RFP was detected uniquely throughout the
epidermis indicating efficient viral transduction of the skin epithelium. eGFP was not
activated until IMQ was administered, underscoring the potential of the post-inflamed
unique chromatin domains to drive gene expression and to act as sensors of tissue
damage (Figure 2.13 D).
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Next, we hypothesized if persisting inflammation-induced open chromatin domains
are physiologically relevant to the functional EpSC memory, then they should participate in the accelerated wound-repair response that we observed in inflammationexperienced mice. To test this possibility, we wounded the skin of day 30 postinflamed mice, and 12 hours later we evaluated the transcriptional response of EpSCs
within an approximately 0.5 mm+ radius of the wound edge (Figure 2.14 A). In parallel,
we performed RNA-Seq on epidermal EpSCs from control and IMQ-treated skin at
the peak (D6) and post (D30) inflammation (Figure 2.14 B). Consistent with epidermal
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pathology at the peak of inflammation, EpSCs isolated from D6 IMQ skin displayed
notable changes in the transcriptome relative to their control counterparts. Changes
correlated well with genes featuring newly acquired ATAC-seq peaks with 91% of differentially expressed genes being associated with newly acquired ATAC-peaks (Figure 2.14 C). While only a few of these genes were still transcribed at day 30 (false
discovery rate (FDR)¡0.5), this picture rapidly changed upon wounding. Of the 140
genes differentially upregulated in post-inflamed wound-edge EpSCs 12 hours following injury, 73 (52%) were associated with ATAC-seq peaks that were acquired during
and sustained after IMQ treatment (FDR0.05) (Figure 2.14 D). Given that wound reepithelialization did not peak until day 5 after wounding, this early activation of genes
associated with inflammation-experienced chromatin accessible regions was notable.
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twice.
2.2.7

Downstream effectors of EpSC memory

To understand how these ’inflammatory memory’ chromatin elements might confer
a wound repair advantage, we first performed pathway analysis of the rapid-response
transcripts (adjusted P0.05) of the genes that contain these chromatin domains. One
of the top most enriched pathways was ’inflammasome signaling’ (Figure 2.15 A).
This pathway included AIM2, which has previously been implicated in skin disease
and cancer, as well as other downstream components of the AIM2 inflammasome
including Casp1 and Il18. Notably in EpSCs, both Aim2 and Il18 loci exhibited
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inflammation-induced chromatin accessibility, which was sustained long-term. Aim2
was of particular intrigue because it was one of three genes differentially upregulated
in EpSCs at days 30 and 180 after inflammation, as well as after wounding (Figure
2.15 B). Furthermore, Aim2 upregulation was sustained in inflammation-experienced
skin depleted of its RORC population reaffirming that the EpSC memory response
did not rely on RORC+ cells (Figure 2.15 C).
To test the role of AIM2 in inflammatory memory, we performed loss- and gain-offunction studies. For loss of function studies, we used Aim2-null mice, which mounted
a full inflammatory response to IMQ. However, post-inflamed Aim2-null mice failed to
show a wound healing advantage (Figure 2.15 D). To determine if upregulated Aim2
gene expression was sufficient to endow mice with accelerated tissue repair, we engineered and tested mice whose skin epithelium contained a lentiviral-transduced
doxycycline-inducible Aim2 cDNA (TRE-Aim2) (Figure 2.15 E). In the absence of
IMQ preconditioning, increased expression of Aim2 was sufficient to enhance wound
repair (Figure 2.15 F). All together, these experiments revealed AIM2 as a key mediator in endowing inflammation-experienced EpSCs with their heightened sensitivity
to a secondary assault.
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(OE) of epithelial Aim2. F OE of Aim2 is sufficient to augment wound healing in naive
mice (n=2). Data are mean ± s.e.m. Rate calculated from wound area. TRE, tetracycline response element. n denotes the number of biologically independent animals.
Experiments replicated at least twice.
After confirming AIM2’s importance to post-inflamed accelerated wound healing,
we sought to determine if the effect was due to AIM2’s canonical role in the inflammasome pathway or as recent reports indicate its suppression of stem cell proliferation. In the intestine, AIM2 suppresses stem-cell proliferation in indirectly inhibiting
phosphorylated AKT(Ser473). However, in the epidermis, post-inflamed wounds had
higher levels of pAKT (Ser473) and equal numbers of proliferating EpSCs to control
wounds (Figure 2.16 A). Taken together, we decided to focus on AIM2’s role in the
inflammasome pathway that is triggered after infection or tissue damage.
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Figure 2.16: CASP1 and IL-1β downstream of the AIM2 inflammasome enhance
wound re-epithelialization in inflammation-experienced skin. A pAKTS473 expression
in D1 wounds in PI and naive skin, scale bars (sb) = 100µm. B Diagram of AIM2
and its downstream effectors. (C) TUNEL labeling of D1 wounds in PI and naive skin,
sb = 50µm. D Elevated levels of Casp1 transcript (**P=0.0025) and CASP1 activity
(**P=0.0014) in PI skin 12hr after wounding, n=3. D Schematic depicts experimental design. Ac-YVAD-cmk reduced CASP1 activity and re-epithelialization rates of
wounded, PI skin to naive, vehicle control levels (**P=0.0018). E Increased levels
of Il18 transcipts (**P=0.0014) and also IL-18 (*P=0.0202) and IL-1β (**P=0.0073)
protein in PI skin post-wounding, n=3. F Loss of Il18 does not effect the injury response of PI skin, n=3 (WT, *P=0.0146; KO, **P=0.0019). G Loss of Il1r1 abrogates
the enhanced injury response of PI skin n=4 (WT, *P=0.0155; KO, P=0.0086). H IL1β, but not IL-18 (50 ng/ml ea), accelerated outgrowth of Krt14+ keratinocytes in D5
ex vivo explants. Dotted lines mark borders of outgrowths; red lines denote migration distance, n=3; 3 technical reps per mouse (*P=0.00128). Quantification at right,
sb 500 µm. I Anti-IL1R1 treatment reverses the wound repair advantage conferred
by epidermal Aim2 overexpression in naive mice, n=4 (IgG, **P=0.0055, anti-IL1R1
***P=0.0007). All plots represent mean ± s.e.m. All experiments, except H, repeated
at least 2X. Significance: two-tailed t-test (95% confidence).
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AIM2 is a cytosolic double-stranded (ds) DNA sensor. When AIM2’s HIN domain
binds dsDNA, the inflammasome complex is oligomerized and a complex member
protein, ASC, subsequently recruits procaspase-1 to the complex resulting in autoactivation of caspase-1 (CASP1) (Figure 2.16 B). CASP1 is a central downstream effector of AIM2, and both its transcription and enzymatic activity were rapidly initiated
within 12 hours after injury in post-inflamed skin relative to naive controls (Figure 2.16
C). Moreover when the ability of CASP1 to process the pro-forms of cytokines IL-1β
and IL-18 was blocked by the inhibitor AC-YVAD-cmk, rates of wound healing were
reduced to naive levels in inflammation-experienced skin, while remaining unaffected
in naive control skin (Figure 2.16 D). This loss of the inflammation-induced wound
healing advantage was not attributable to CASP-1 dependent pyroptosis, as both
control and post-inflamed wound edge EpSCs exhibited minimal and equal levels of
cell death (Figure 2.16 E).
After determining that CASP1 was also a downstream effector of inflammatory
memory, we decided to work further down the pathway and assess the contribution
of pro-inflammatory cytokines IL-18 and IL-1β. Indeed, post-inflamed skin displayed
increased Il18 transcription and levels of IL-18 and IL-1β proteins compared to naive
skin (Figure 2.16 F). To determine whether AIM2 acts through cytokine production to
accelerate wound repair, we repeated our experiments with Il18 and Il1r1-null mice.
We found that while IL-18 was dispensable, without IL-1R1, which is required for IL1β signaling, inflammation-experienced skin failed to enhance wound repair (Figure
2.16 G, H). To further confirm these results, we returned to the ex vivo wound healing
model of the explant migrant assay, whereby we added recombinant cytokine to control explants and assess outgrowth. Consistent with our in vivo findings, the addition
of recombinant IL-1β, but not IL-18, enhanced the migration of keratinocytes from
naive skin explants (Figure 2.16 I). We next hypothesized that if AIM2-mediated IL-1β
secretion was responsible for acclerated re-epithelialization of post-inflamed wounds,
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then blocking IL-1β signaling should counteract inducing overexpression of Aim2. To
this end, we injected IL-1R1-blocking antibodies into doxycycline-treated TRE-Aim2
mice, and observed the rate of wound closure was comparable to that of untreated
naive control mice (Figure 2.16 J). Taken together, these data point to AIM2 and
its downstream effectors CASP1 and IL-1β as central regulators of the heightened
wound-repair response observed in inflammation-experienced skin.
2.2.8

Chromatin rearrangements in the absence of AIM2

Genetic ablation of AIM2 resulted in loss of the post-inflamed accelerated woundhealing phenotype. However, it remained to be determined whether loss of augmented tissue repair was a failure of Aim2 null mice to remodel their chromatin to
establish memory or if upregulation of AIM2 following inflammation was necessary
for rapid release of pro-wound healing cytokines such as IL-1β. First to address this
question, I confirmed that AIM2KO mice elicited an IMQ inflammatory response that
paralleled WT mice. Second, I performed ATAC-Seq on Aim2 null (AIM2KO) mice at
the peak of inflammation and after resolution to address what may have accounted
for the loss of the post-inflamed wound healing advantage.
In the absence of Aim2, mice were capable of mounting a full inflammatory response with infiltration of CD45+ immune cells and CD3+ T cells (Figure 2.17 A). EpSCs responded to the immune cell infiltrate and resulting proinflammatory cytokine
storm by ramping up proliferation as indicated by EdU incorpation after a 1 hour pulse
(Figure 2.17 B). The basal proliferation rate of EpSCs in both WT and AIM2KO shifted
from approximately 5% EdU incorporation within the hour to greater than 40%. As a
result, there was severe epidermal hyperthickening and hyperdifferentiation in both
WT and KO inflammatory responses (Figure 2.17 C). Importantly, mice were able to
resolve this inflammation in the absence of Aim2 indicated by a return to basal proliferation rates, homeostatic epidermal thickness, and recession of the immune infiltrate
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(Figure 2.17 A-C).
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Figure 2.17: AIM2KO mice mount a robust inflammatory response that resolves 30
days later. A Immunoflourescence of CD45+ immune cells and CD3+ T cells in WT
and AIM2KO mice peak and post inflammation. B Immunofluorescence of EdU incorporation after a 1 hour pulse in WT and AIM2KO mice peak and post inflammation. C
Immunofluorescence of Keratin 10 (Krt10, marker of differentiated keratinocytes) and
Keratin 14 (Krt14, marker of basal keratinocytes) in WT and AIM2KO mice peak and
post inflammation. Scale bars = 100µm.
As described previously, epithelial stem cells were purified from tissue at the peak
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of inflammation and after resolution. Two independent biological replicates were performed for each AIM2KO condition and sequenced on the Illumina HiSeq2500 platform for comparison to the previously acquired WT ATAC-seq data set. All replicates
with the exception of the D30 AIM2KO Ctrl, where Replicate 2 had a low read count,
were highly correlated with R2 values 0.81 (Figure 2.18 A). AIM2KO ATAC-signals
were similarly distributed over various genomic and intergenic regions for all conditions. Additionally, there was no difference in ATAC-signal distribution between WT
and AIM2KO samples (Figure 2.18 B).
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Figure 2.18: Chromatin remodeling occurs in the absence of AIM2. A Table depicts
total reads, reads per replicate (R), peaks called, and replicate correlation coefficients
for WT and AIM2KO ATAC-Seq (n= 3 pooled mice per group). B Distribution of ATACseq peaks within defined genomic regions. UTR, untranslated regions of predicted
mRNAs. C Venn diagram depicting the intersect between D6 AIM2KO IMQ ATAC
peaks and D6 AIM2KO Ctrl peaks. Plot below is top 8 GO Biological Processes
enriched for 29667 D6 AIM2KO IMQ unique chromatin domains. D Venn diagram of
overlap between WT and AIM2KO unique IMQ ATAC peaks. Plot below depicts top
8 GO Biological Processes enriched for 19498 shared peaks. E Transcription factor
(TF) motif enrichment within shared WT and AIM2KO D6 IMQ peaks. F Top 8 GO
Biological Processes enriched in ATAC peaks unique to the WT IMQ response. n
denotes the number of biologically independent animals. Experiments replicated at
least twice.
As in WT EpSCs, there was an appreciable difference in chromatin accessibility patterns between D6 IMQ EpSCs and control EpSCs. There was an increase in
accessibility at the peak of inflammation with a total of 29,667 (31% of total) unique
regions emerging (Figure 2.18 C). These unique chromatin domains were associated with pathways involved in cholesterol and fatty acid metabolism, the inflamma43

tory response, apoptotic signaling among others. To address whether the loss of
Aim2 impacted the inflammatory response at the chromatin level, I compared the
AIM2KO data to the WT data. While there were more peaks called in D6 IMQ WT
EpSCs (44,414), this still represented 31% of the total peaks called; the same ratio as for AIM2KO. Of the unique WT and AIM2KO IMQ chromatin regions, 19,498
were common between the two samples (Figure 2.18 D). Shared chromatin domains
corresponded to biological processes such as cholesterol metabolism, EGFR signaling, and the inflammatory response. Additionally, these domains were enriched for
transcription factors both associated with inflammation and EpSC homeostasis including BATF, KLF5, AP2, CEBPB, RUNX1, and ATF4 among others (Figure 2.18 E).
To determine what was unique to the WT response, we assessed the 24916 unique
chromatin regions and determined that the domains were associated unique processes such as cellular hormone metabolism, IL-4 production, protein lipidation, and
positive regulation of histone modification among others (Figure 2.18 F). It remains
to be determined if these differences at the peak of the inflammatory response are
responsible for the loss of accelerated wound healing post inflammation.
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Figure 2.19: Chromatin rearrangements retained post-inflammation in absence of
AIM2. A Venn diagram depicting overlap between D30 PIMQ AIM2KO and control
ATAC peaks. B Venn diagram depicting chromatin accessibility gained at the peak of
the AIM2KO inflammatory response and retained at D30. Adjacent plot of top 8 GO
Biological Processes for AIM2KO memory domains. C Comparison between WT and
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After establishing that inflammation-induced chromatin rearrangements occurred
at the peak of inflammation in the absence of Aim2, I next wanted to determine if
these changes were retained after resolution of inflammation. At D30, there were
19,492 (26% of total) unique peaks compared to control (Figure 2.19 A). This difference was larger than what was observed for WT (9,561 peaks). However, when I
looked specifically at the memory domains or chromatin regions that became accessible at the peak of inflammation and then retained an open state after resolution,
there were 1,986 regions (Figure 2.19 B). These AIM2KO memory domains were associated with distinct pathways from the WT such as negative regulation of protein
phosphorylation, Ras protein signaling, DNA damage response, and negative reg45

ulation of transferase activity. These difference in pathways was supported by the
small degree of overlap (261 chromatin regions) between the two sets of memory domains (Figure 2.19 C). Next, I wanted to determine if AIM2KO memory domains were
associated with the previously identified 140 rapid response post-inflamed genes 12
hours after wounding. 29% (41) of the rapid response genes did have an associated
AIM2KO memory domain. 22 of these 41 were shared with the wild type response
(Figure 2.19 D). It remains to be determined whether the loss of the post-inflamed
wound healing advantage in AIKM2KO mice is due to the identified differences in the
memory domains, rapid response genes, or that upregulation and maintenance of
AIM2 in the interim is required for rapid release of IL-1B.
2.2.9

Inflammatory memory can be maladaptive

Thus far, we have demonstrated that inflammatory memory is largely an adaptive
mechanism adopted by stem cells to cope with and better prepare for inflammatory
stress. We determined that retained chromatin accessibility at key inflammatory response pathways enabled accelerated tissue repair in post-inflamed mice. While this
accelerated wound healing is largely beneficial, we wanted to understand whether
inflammatory memory’s advantage is context specific. We therefore addressed if in
a tumor susceptible environment, these same pathways would potentially augment
tumorigenesis.
To address this problem, we implemented the two-step skin carcinogenesis model
[71]. Briefly, a subcarcinogenic dose of the carcinogen, 7,12-Dimethylbenz(a)anthracene
(DMBA), was applied topically to the back skin of both post-inflamed and inflammationnaive mice. DMBA is a mutagen causing EpSCs and keratinocytes to acquire mutations. A primary target of DMBA is Hras1, which acquires activating mutations predominantly an A to T (182) transversion [72]. DMBA treatment serves as the tumor
initiation step. Mice are then subsequently treated with a tumor-promoting agent, 12-
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O-Tetradecanoylphorbol-13-acetate (TPA), which promotes clonal expansion of mutated EpSCs via increasing proliferation and inducing epidermal hyperplasia. It is
thought that initiated cells have a growth advantage over their neighbors resulting in
their selective expansion leading ultimately to tumor development [73]. The two-step
skin carcinogenesis model results in papillomas that have the potential to progress to
full blown squamous cell carcinomas.
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Figure 2.20: Post-inflamed mice are more susceptible to two-step carcinogenesis. A
Schematic of DMBA-TPA model of skin carcinogenesis. B Plot depicts the number of
tumors (papillomas) per mouse over time. n=3. P-value0.0001. Experiment included
three mice per group. Statistical analysis for B performed with an ANOVA. GPower
software used to determine that N=3 in each group with an observed effect size of
6.467 and a significance level set at 0.05 achieved 0.9998517 power.
After resolution of inflammation (D30), post-inflamed mice and inflammation-naive
mice were topically treated with DMBA. One week after tumor initiation, mice were
treated two times per week with topical TPA (Figure 2.20 A). Tumors began to appear
11 weeks after the initial exposure to DMBA in post-inflamed mice, 3 weeks earlier
than in controls (Figure 2.20 B). Over the duration of the experiment, post-inflamed
mice had a significantly higher tumor burden with an average of roughly 17 papillomas
per mouse compared to the 5 in control mice. To determine the possibility that this
observation was due to a false negative, the GPower software was used to calculate
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the power achieved by this study. At week 23, the final time point collected, the mean
number of tumors for the control group was 5.67 and 18.33 for the post-inflamed,
with a standard deviation of 1.16 and 2.52, respectively. The observed effect size
for this experiment was 6.47 with 3 mice in each group. With a significance level set
at 0.05, the achieved power from this experiment was 0.9998517 indicating that the
observations are not due to a false negative.
These initial observations indicate that inflammatory memory can be maladatpive
leaving the mouse more susceptible to carcinogenesis in an inflammatory microenvironment. More work is needed to determine the potential contribution of the altered
skin niche (i.e. increased frequency of RORC+ cells) to tumorigenesis. Additionally,
we need to elucidate the retained accessible chromatin domains in post-inflamed
mice that contribute to increased susceptibility to tumorigenesis. These observations
beg the question of whether the adaptive features of inflammatory memory can be
distinguished from the maladaptive ones.

2.3

Discussion

Tissue adaptation to inflammation has largely been attributed to innate immune
memory within macrophages and natural killer cells, or to the persistence of memory
in tissue resident T cells. Recent studies suggest that immune cells ’remember’ a
primary inflammatory stimulus by maintaining certain chromosomal and/or transcriptional features that were induced at the time of the assault. Here we provide powerful
evidence that in contrast to prevailing notions, inflammatory memory is not merely
a specialized property of immune cells, but rather also a feature of long-lived epithelial stem cells. Building upon the paradigm set for memory T cells, we now find
that unexpectedly, EpSCs induce and sustain long-term changes to their chromosomal landscape in response to inflammation. Moreover, these changes endow EpSCs
with the ability to accelerate their response to subsequent stressors. Analysis of the
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myriad of potential contributing factors offers areas for future research. For instance,
although the overall numbers of basal skin cells remained unchanged, distinct pools
of EpSC that do not participate in naive skin responses might become sensitized to
do so as a result of inflammation.
The majority of EpSC chromatin changes sustained long-term after the primary
inflammatory exposure were not accompanied by sustained transcription of their associated genes, nor did inflammation-induced transcription factors remain active. The
paradoxical issue is how then do these chromatin regions remain accessible in EpSCs long-after the return to normal epidermal homeostasis. Our existing evidence
indicates and working hypothesis suggests EpSC transcription factors and other chromatin modifiers present in normal homeostasis can propagate these chromatin sites
made accessible during inflammation.
Although the underlying mechanisms are complex, our in vivo reporter analyses
indicate that sustained open-chromatin domains possess the information needed to
sense tissue damage. Moreover, by remaining open long after inflammation resolves,
these sensors seem to have functional relevance to the secondary assault. Consistent with this notion, greater tahn 50% of genes induced early and selectively at the
wound edge of inflammation-experienced skin were associated with these sustained
open-chromatin domains.
The active transcription of Aim2 post-inflammation along with other components
of the inflammasome pathway in the rapid responders gene list provided a clue to the
downstream mediators of inflammatory memory. Our loss- and gain-of-function studies with AIM2, CASP1, IL-1β, and IL1-R1 underscore the importance of this pathway
in conferring a wound repair advantage to inflammation-experienced EpSCs.
As beneficial as it may seem, heightened sensitivity to tissue damage may not
always be a blessing: genetic alterations that mobilize stem cells more rapidly are
often associated not only with accelerated wound repair, but also increased cancer

49

susceptibility. Indeed, individuals with gain-of-function mutations in inflammasome
components are known to have increased risk of epidermal hyperplasia and cancers. Our findings suggest that the inflammation-induced memory imparted to EpSCs may also underlie the recurrent and exacerbated skin inflammation displayed by
patients with autoimmune disorders such as psoriasis and atopic dermatitis. Overall,
the inflammation-induced rewiring of EpSCs that we have unearthed here is likely to
have major implications for future therapeutics aimed at enhancing adaptive features
and counteracting maladaptive ones.
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CHAPTER 3

RETAINED HISTONE MODIFICATIONS DEFINE INFLAMMATORY MEMORY

3.1

Introduction

Inflammatory memory endows stem cells with enhanced responsiveness to subsequent challenges. This memory is a result of chromatin rearrangements that open
and maintain accessibility at key immune response pathways long-term. These memory domains enable rapid upregulation of key genes that enable accelerated tissue
repair and heightened stem cell sensitivity [74]. How this memory forms and more
importantly why only a subset of these chromatin domains stay accessible remains
to be elucidated.
Gene expression patterns can be predicted by the histone code, which consists of
post-translational modifications to histone tails that facilitate recruitment of chromatin
remodelers and transcriptional machinery [41]. By assessing histone modifications
over these memory domains and the genome at large, we can glean what is unique
about these chromatin regions. Based on the marks deposited during the peak of the
inflammatory response and retained afterwards, we can hope to both elucidate the
initial chromatin rearrangements that lead to establishment of inflammatory memory
and identify potential mechanisms for its retention. While this work remains ongoing,
we thus far have identified that identified specific retention of monomethylation of
Histone 3 lysine 4 (H3K4me1) at these memory chromatin domains.
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3.2

Results

3.2.1

Increase in active chromatin detected at the peak of inflammation with global
histone modification patterns restored after resolution

To address changes to the chromatin landscape during and after resolution of
inflammation, we returned to the self-resolving model of acute Imiquimod (IMQ)induced skin inflammation. The peak of the inflammatory response occurs 6 days
after consecutive daily treatment, and resolves 30 days later (post-inflamed). EpSCs
were collected from the skin as described previously, excluding potential contaminating cell populations. EpSCs were then prepared for multiplexed indexed T7 chromatin
immunoprecipitation with high throughput sequencing (MINT ChIP) [?]. This assay
enables both individual samples and antibodies to be barcoded enabling submission of one pooled library containing all samples with multiple histone ChIPs (Figure
3.1). Briefly, chromatin from each sample was digested with micrococcal nuclease
(MNase) and barcoded with a T7 adaptor. Next, samples were pooled together and
redistributed for incubation with individual histone antibodies. Each antibody pool
then received an individual Illumina barcode, after which each pool was combined at
equal concentrations and submitted for sequencing. The major advantages of this
technique is it requires small cell numbers (200K), is cost-effective (20 ChIPs in one
go), and is quantitative. Total histone 3 (TH3) is included as one of the antibodies, and enables signal normalization of modified histone 3 antibodies to the total
H3 input. The histone modifications assessed using MINT ChIP included: H3K27ac,
H3K4me1, and H3K27me3.
The histone modifications assayed were selected to distinguish active from poised,
primed, and repressed chromatin [75] [76]. H3K27ac marks active enhancer regions.
H3K4me1 marks primed chromatin, likely once active and left accessible for reactivation [49]. H3K27me3 is associated with repressed promoter regions; however, is also
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Figure 3.1: Multiplexed indexed T7 ChIP-Seq enables quantitative comparisons of
histone modifications on small cell numbers. Schematic of MINT ChIP experimental
design.
found in bivalent chromatin domains containing active marks such as H3K4me3 [77].
Bivalent chromatin is poised for activation, but has a repressive mark that prevents
active transcription until the necessary activation signal is present.
A total of three replicates were completed for MINT ChIP. Across samples we
observed similar frequencies of reads mapped, multimapped, unmapped, and duplicates (Figure 3.2 A). Replicates 2 and 3 were run on the Illumina HISeq2500, which
achieves a sequencing depth of approximately 160 million. Replicate 1 (R1) was run
on the Illumina NextSeq, which can achieve greater sequencing depth with closer to
400 million total reads. Samples from R1 therefore have more total reads than R2
and R3 (Figure 3.2 B).
At first, MINT ChIP was performed separately for day 6 and day 30 samples. However, we observed a batch effect that made quantitative temporal comparisons difficult. Therefore, for the last replicate (R1) we simultaneously ran D6 and D30 samples
for each condition. This facilitated normalization both to total H3 and to total reads.
Normalization ratios of modified histones over total H3 revealed subtle differences
at the peak of inflammation such as increased H3K27ac and reduced H3K27me3.
However, these differences were not sustained post-inflammation. (Figure 3.3 A).
Globally histone modifications largely looked similar across time and conditions. This
observation is confirmed by western blots of whole cell lysates, where there is no
overt difference in global histone modifications (Figure 3.3 B).
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Figure 3.2: Alignment metrics for MINT ChIP on EpSCs peak and post inflammation. A Average frequencies of reads mapped, unmapped, duplicates, and uniquely
aligned. B Table depicting total reads and reads uniquely aligned to the mouse
mm10 genome after filtering out T7 duplicates, PCR duplicates, unmapped and multimapped reads. MINT ChIP was performed in triplicate with 3 mice per group.
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Figure 3.3: Normalization ratios of histone modifications over total H3. A Normalization ratios for each sample from replicate 1. B Western blot images of histone
modifications from whole cell lysates of 10K cells.
Principal component analyses for each histone modification also identifies D6 IMQ
as unique, and D30 post-inflamed (PIMQ) as more closely correlated with the controls
(Figure 3.4). Specifically for H3K27ac, H3K4me1, and H3K27me3, D6 IMQ clusters
distinctly from the other samples. Intriguingly, the D30 PIMQ samples appeared further along PC1 in the direction of D6 IMQ for H3K4me1 than the controls indicating
more similarity and potential biological meaning.
All in all these global histone patterns matched our expectations: minimal sustained global differences in the histone code post-inflammation in accordance with
our prior ATAC-Seq data where a majority of the inflammation-induced chromatin accessibility resolved by D30 PIMQ.
3.2.2

Maintenance of inflammation-induced histone modifications over memory domains

An important question following the establishment of inflammatory memory is why
only a small subset of chromatin domains remain accessible after resolution of inflammation. At the peak of the inflammatory response, there were 44,414 uniquely
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Figure 3.4: PCA confirms majority of inflammation-induced histone modifications resolve. PCA plot broken down by individual histone modification. Each MINT ChIP
replicate is plotted as an individual dot.
ATAC peaks that had emerged, but only a small fraction, specifically 2,037 (roughly
4.5%) remained accessible. These peaks were functionally significant in that they
were associated with genes that were rapidly upregulated upon a secondary injury
contributing to EpSCs enhanced responsiveness. The question remains what is special or unique about these memory ATAC domains that keep them accessible?
To address this question, we returned to our MINT ChIP data and took the 2,037
memory ATAC domains and assessed histone ChIP signal specifically over these regions (Figure 3.5 A, B). As expected at the peak of the inflammatory response, we
see a sharp increase in H3K27ac signal indicating active chromatin. The peak of
inflammation is where we observed robust transcriptional changes, and it is therefore
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apt that the associated chromatin would be active. H3K27ac is not retained postinflammation, which fits considering that resolved EpSCs differentially express only a
handful of genes. These sites uniquely retain H3K4me1 post-inflammation suggesting the chromatin is accessible and primed for reactivation. As the above projects
are ongoing and for the purpose of this dissertation, the remainder of this chapter will
discuss H3K4me1 and enhancer regions.
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H3K4me1 normalized
ro H3 Scaled
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Figure 3.5: Post-inflamed EpSCs retain H3K4me1 in memory domains. A Heat map
of H3K4me1 ChIP signal normalized to total H3 and scaled to a million over ATAC
memory domains for each sample. B Plots depict signal intensity for each ChIP normalized to total H3 and scaled to a million centered over the ATAC memory domains.
Data presented from replicate 1 of MINT ChIP data set.
H3K4me1 marks active and primed enhancers, which are distinguishable by the
presence of H3K27ac [51]. Recent work suggests that H3K4me1 is involved in fine
tuning enhancer activity through recruitment of chromatin remodelers such as the
BAF complex and inhibition of de novo methylation machinery [78] [79] [80]. The lack
of DNA methylation at these enhancer regions in addition to their ability to recruit
chromatin remodelers enables H3K4me1 marked enhancers to rapidly respond to
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environmental cues to influence expression of their associated genes [75]. The rapid
response nature of H3K4me1 marked enhancers makes them an enticing subset of
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Figure 3.6: De novo enhancers emerge at the peak of inflammation and are retained.
Genomic browser views of two emergent enhancer regions within memory ATAC domains that gain H3K4me1 and H3K27ac at the peak of inflammation, and remain
primed in the interim by retaining H3K4me1. These enhancer regions are associated
with immune response genes left, Cxcl13 and right, Trim8.
As the heatmap in Figure 3.5 A shows many of the memory domains possess
H3K4me1 across conditions. However, a subset of these regions gained H3K4me1
uniquely at the peak of inflammation. The development of ”de novo” enhancers or
reactivation of latent enhancers was recently described in macrophages, where upon
activation sequential binding of stimulus-activated and lineage-specific TFs facilitated
deposition of enhancer marks [75]. After withdrawal of the stimulant, these latent
enhancers remained primed with H3K4me1. Here we find that our de novo H3K4me1
enhancers are active at the peak of inflammation as they are simultaneously marked
by H3K27ac, and after resolution they retain the H3K4me1 mark but lose the active
marks (Figure 3.6). Furthermore, HOMER Motif analysis of these 2037 memory
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domains reveals enrichment of both inflammatory and EpSC-specific TFs specifically
FRA1 (member of AP-1 family), ELF3, CEBPB, SMAD2, and KLF5. It is plausible that
a similar mechanism as identified in macrophages is at play in EpSCs.

3.3

Discussion and Future Directions

Inflammatory memory is an intrinsic feature of EpSCs, but how it is formed and
more importantly retained remain works in progress. To understand retention of memory domains, we plan to interrogate which inflammatory and EpSC-specific TFs are
enriched and bound to these regions through ChIP-Seq experiments. While Otsuni
et al., found that in macrophages the lineage-specific TF PU.1 did not remain bound
in the absence of an inflammatory stimulus, others have identified more active role
for TFs in orchestrating and sustaining chromatin rearrangements [75] [81] [82]. With
consideration to H3K4me1, we are interested in histone methyltransferases (Mll3/4)
that generate the mono-methyl mark on H3K4: how are Mll3/4 recruited to these chromatin domains and conversely, which histone demethylases do not subsequently remove these marks? Additionally, H3K4me1 inhibits binding of DNMT3L which could
result in a reduction of de novo DNA methylation thereby preventing enhancer repression. To assess the DNA methylation status of EpSCs, we are collaborating with
Alexander Meissner’s group at the Max Planck Institute for Molecular Genetics to perform whole genome bisulfite sequencing on cells collected from the same skin preps
from which the MINT ChIP EpSCs were derived.
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CHAPTER 4

SUMMARY AND PERSPECTIVES

4.1

More than just the skin: adult tissue stem cells remember inflammation

Tissue stem cells sense and respond to environmental cues, which influences
their decision between quiescence and activation, self-renewal and differentiation.
Beyond simply influencing the immediate outcome of a round of division, these environmental cues educate stem cells so they are primed to respond to future encounters. This concept was first developed in innate immune cells and termed trained
immunity, but recently this is a phenomenon found to occur within tissue stem cells.
Trained immunity is a nonspecific memory that is coded epigenetically or metabolically within a cell after an inflammatory event that primes the cell to respond quicker
and more efficiently to secondary inflammatory assaults or infection. This epigenetic
memory can be established through a myriad of alterations including but not limited
to changes in chromatin accessibility, DNA methylation, histone modifications, modulation of miRNA, and long-noncoding RNA expression [66]. Upon secondary challenges, this education results in expeditious transcriptional activation of key genes
that function to defend against infection to either protect the stem cells or bias their
lineage determination.
The ability of stem cells to both self-renew and differentiate means that alterations
to their epigenome will be sustained and propagated within a tissue throughout an
organism’s lifetime. In the case of fighting off future infection, these changes are
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highly beneficial. Recent work highlights that administration of Bacillus CalmetteGuérin (BCG), a vaccine used against Mycobacterium tuberculosis(Mtb), to bone
marrow results in reprogramming of hematopoietic stem cells (HSCs). Following exposure to BCG, these HSCs alter their transcriptome resulting in lineage bias towards
myelopoiesis over lymphopoiesis. Resulting bone marrow-derived macrophages (BMDMs)
from BCG-educated HSCs are epigenetically modified, with more H3K27ac in putative enhancer regions leading to significantly higher expression of immune-related
genes including Ifng, Tnf, and Il1b during Mtb infection. Rapid transcription of these
antimycobacterial immunity genes enables trained macrophages to confer significantly better protection against Mtb than naı̈ve macrophages. Subsequent bone
marrow transplant experiments demonstrate that HSC reprogramming is sustainable in the absence of BCG, substantiating that these HSCs are bona fide memory
HSCs [83].
As a proof of concept that HSCs and their progenitors (HSPCs) can indeed be
trained and develop a long lasting memory, β-glucan considered to be the prototypical
trained-immunity agonist was intraperitoneally injected into mice, which resulted in a
long term sustained increase in myelopoiesis. While, HSCs do not express the βglucan receptor Dectin-1, it was found that β-glucan triggered IL-1B related bone
marrow inflammation mediated trained immunity of HSPCs. Trained HSPCs were
significantly better at protecting against systemic LPS, and ameliorating the effect
of replication stress and DNA damage in long term HSCs over naı̈ve progenitors.
Furthermore, β-glucan-trained HSPCs confer a protective hematopoiesis response
to myeloablative chemotherapy via cyclophosphamide or 5-fluoracil. Metabolic and
lipidomic experiments find a reduction in linoleic and arachidonic acid metabolism
as well as broad changes in the lipidome specifically more lipids with shorter (34-36
carbon atoms) and more saturated acyl chains in trained HSPCs over naı̈ve cells.
Taken together IL-1β signaling in conjunction with key metabolic changes results in
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training of HSPCs that confer protection against subsequent infections as well as an
enhanced hematopoiesis response [84].
Trained immunity can also develop after sterile triggers of inflammation such as
feeding low-density lipoprotein receptor (ldlr) null mice a Western diet (WD). The
calorically rich WD is considered to have an inflammatory nature and is tightly linked
to the development of diseases such as type II diabetes, obesity, and cardiovascular disease. Mice fed with WD for four weeks and then shifted back to a classical
diet (CD) experienced transient hypercholesterolemia and a systemic inflammatory
response with circulating growth factors, cytokines, and chemokines. WD induced
an expansion of HSPCs, myeloid progenitor cells (MPPs) and granulocyte-monocyte
progenitor cells (GMPs). GMPs were functionally distinct with enhanced responsiveness to LPS via differentially expressing key type I interferon response genes indicating that they and MPPs were reprogrammed. Assessing chromatin accessibility in
GMPs from WD fed mice reveals enrichment of peaks associated with IL-6 production
and the JAK/STAT pathway. Furthermore, key enhancer regions including Tet2 and
Tlr4 remained more accessible even after mice were switched back to a CD. WD is
sensed by the NLRP3 inflammasome resulting in release of IL-1β. IL1R1 blockade
abrogates WD-induced systemic inflammation, and results in weaker responses upon
secondary LPS challenge following the training period. Altogether transcriptional and
epigenetic data reveal that exposure to WD can sustainably reprogram GMPs as
many of the noted changes persist after return to a CD and that IL-1β is significant to
cellular reprogramming [85].
As previously discussed in this dissertation, the link between inflammation, inflammasomes, IL-1B and reprogramming of stem cells is not unique to the hematopoietic compartment as the AIM2 inflammasome and IL-1B were identified as essential
downstream mediators of EpSC inflammatory memory in contributing to augmented
wound healing post-inflammation. Here I discuss cases where the establishment of
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trained immunity or memory in stem cells has been a positive adaptation resulting
in more efficacious protection against infection and enhanced tissue repair capacity.
However, as previously discussed in Chapter 2 of this dissertation, in a tumor-prone
environment EpSC inflammatory memory leads to accelerated tumorigenesis. Another recent study describes an inflammatory memory phenomenon in respiratory
epithelial progenitors in human allergic inflammatory disease, where polyp cells exhibited a heightened transcriptional response and reinforcement of progenitor programs upon restimulation with pro-inflammatory type 2 cytokines. This rapid recall
and augmented response, after weeks in culture, may offer insights into epithelial
pathology and the chronic nature of allergic disease [86]. Stem cells are superlative at balancing acts, and memory will be another one: a fine-tuned tipping scale
between ’good’ and ’bad’ memories resulting in enhanced tissue fitness or pathogenesis.

4.2

Insights from innate immune cells on stem cell inflammatory memory

Innate immune cells including monocytes, macrophages, and natural killer cells
can recollect prior exposure to a pathogen or damage associated molecular pattern
and mount immunological memory. This memory results in an augmented and nonspecific response to future encounters with either a similar or unrelated inflammatory
stimulus. Work in innate immune cells has elucidated the metabolic reprogramming
and epigenetic rewiring that take place to establish immunological memory. Here, I
will discuss the recent work in this space and comment on how it relates to the work
presented in this dissertation.
4.2.1

Insights into metabolic reprogramming

Training of monocytes with β-glucan identified an important metabolic shift sustained in educated monocytes. These monocytes ramped up glycolysis in an AKT/mTOR/HIF1α
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dependent manner resulting in increased glucose consumption and pyruvate to lactate conversion [87]. Training with BCG resulted in a similar metabolic shift with the
addition of increased oxygen consumption [88]. Despite the shift towards glycolysis,
trained macrophages possessed elevated levels of TCA metabolites including citrate,
succinate, malate, fumarate, and 2-hydroxyglutarate fueled instead by glutaminolysis. These TCA intermediates likely played an important role in the training process
as inhibiton of glutaminolysis via BPTES is sufficient to prevent formation of trained
immunity by either β-glucan or BCG [88] [89]. Arts et al., also find upregulation of a
large number of cholesterol biosynthesis genes during induction of trained immunity.
Atorvastatin-mediated inhibition of HMG-CoA-reductase, the rate-controlling enzyme
in the mevalonate pathway that leads to production of cholesterol, resulted in diminished induction of trained immunity [89] highlighting the importance of sterol synthesis.
Reliable ex vivo metabolomics has proved a challenge for the field as a whole, and
renders assessing individual metabolites in isolated EpSCs presently an unattainable
goal. However, our current work suggests that many of the same players are essential to EpSC inflammatory memory. For instance, our MINT-ChIP data led us to HIF1α
and mTOR signaling as important signaling pathways during the primary response in
contributing to formation of inflammatory memory. Additionally, the D6 IMQ ATAC-Seq
data set reveals cholesterol biosynthesis and sterol metabolism as the most significantly enriched pathways. As a rudimentary read out for an increase in glycolysis,
we see an abundance of phosphorylated pyruvate dehydrogenase, which suggests
pyruvate is not entering the mitochondria and instead may be converted to lactate. To
more rigorously address the metabolic status of these EpSCs both during the primary
response and after resolution of inflammation, we are establishing an ex vivo human
skin raft culture system, where primary normal human epidermal keratinocytes stratify to form each epidermal layer when exposed to an air-liquid interface (Figure 4.1
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A). After stratification, administration of proinflammatory cytokines IL-17A, IL-22, and
TNF-α recapitulates a psoriatic inflammatory response as indicated by phosphorylation of Stat3Tyr705 (Figure 4.1 B). This system will enable us to profile individual
metabolites, lactate production, and oxygen consumption in each condition.
B
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α-Tubulin
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Krt14 Filaggrin DAPI

Figure 4.1: Primary normal human epidermal keratinocytes stratify to form skin
equivalents and are responsive to pro-inflammatory cytokines. A Top-down view
of immunofluorescence images of human skin rafts depicting basal epidermal layer
(Krt14), differentiated layer (Krt10 or Filaggrin), and nuclei. Right most image includes
sagittal view (below and right side) depicting basal layer (green) on bottom with differentiated suprabasal layers (red) on top. B Western Blot for phosphorylated Stat3
on Tyr705 and α-tubulin in human skin rafts that were unstimulated or stimulated for 3
days with 3 ng/mL each of IL-17, IL-22, and TNF-α. Courtesy of Christopher Cowley.

4.2.2

Insights into epigenetic rewiring

Induction of trained immunity requires large scale epigenetic rewiring involving
histone modifications, changes in DNA methylation, and recruitment of transcription factors/ chromatin remodelers [90] [91] [92] [93] [94]. Seminal work by Ostuni
et al., demonstrated the dynamism of epigenetic reprogramming through identification of the expansion of the cis-regulatory repertoire upon macrophage stimulation. They identified that upon stimulation, macrophages recommissioned latent enhancers, which prior were unmarked and lacked transcription factor (TF) occupancy.
After withdrawal of the stimulant, macrophages rapidly lost H3K27ac (active) and
PU.1 (master regulator), but retained H3K4me1 long term, which enabled faster and
stronger induction of the associated genes [75]. Regarding DNA methylation, differential methylation was stimulant dependent, where LPS-treated cells resulted in
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a distinct methylation pattern but β-glucan had minimal effect. In LPS-treated cells,
most of the differentially methylated regions occurred at distal enhancers [95].
These epigenetic marks require a series of writers, erasers, and readers, which
upon stimulation are activated to modify the chromatin and interpret the resultant
change. For instance, TLR4 signaling results in the establishment of de novo enhancers through activation of lysine methyltransferases, specifically Mll1, Mll2/4, and
Mll3, mediated deposition of H3K4 methylation [52]. The activation of these modifying proteins provides a link between the metabolic status of the cell and the regulation of chromatin modifications. Metabolites serve as cofactors and/or substrates for
these writers, erasers, and readers making them sensitive to changes in metabolite
pools [96]. For instance, NAD+ and acetyl-CoA influence histone deacetylases and
histone acetyltransferases, respectively; succinate and fumarate can inhibit certain
demethylation reactions; and α-ketoglutarate is an essential cofactor for several lysine
and cytosine demethylating enzymes. A specific example of how the integration of
these pathways influences trained immunity was demonstrated via the accumulation
of fumarate inhibiting lysine demethylase (KDM5), resulting in increased H3K4me3 at
the promoters of genes encoding pro-inflammatory cytokines [89].
The contribution of dynamic transcription factor binding to trained immunity has
not been as thoroughly fleshed out as have other epigenetic modifications. Studies
thus far have identified distinct TF binding motifs within stimulant-specific accessible chromatin regions, which contribute to the distinction of trained from tolerized
transcriptional programs in macrophages [95]. Additionally, recent work found that
upon LPS-stimulation, the stress-responsive TF ATF7, which normally binds to and
causes repression of immune-response related genes, is phosphorylated resulting in
its release from chromatin and the concomitant decrease in the repressive histone
marks [97].
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4.3

Future Directions and Clinical Significance

Thus far, I have demonstrated an adaptive mechanism used by epithelial stem
cells to retain epigenetic memory of inflammatory exposure that functions to heighten
sensitivity to future tissue damage. While much of this dissertation discussed the
tissue repair advantage conferred by inflammatory memory, I also discussed how
the same features can be maladaptive and contribute to tumorigenesis. Along these
lines, this dissertation began with a discussion of remitting and relapsing inflammatory skin disorders namely psoriasis and addressed the need for novel therapies. To
this end, we have addressed some of the outstanding questions in this space including EpSC participation in an active inflammatory response leading to epidermal
hyperthickening and their epigenetic rewiring, but most importantly their survival and
retention in the basal compartment long-term post-inflammation. These observations
beg the question of inflammatory memory’s role in psoriatic flares. If inflammatory
memory is inadequately regulated then these chromatin domains could sustain an
inflammatory response. Does inflammatory memory address in part why the disease
relapses in the same skin location over and over again? Could modulating memory
and retention of these chromatin domains make the EpSCs refractory to aberrant
immune cell signaling or alleviate EpSC feed-forward communication with infiltrating
immune cells? The current findings identify EpSCs an interesting avenue to explore
for the development of novel therapeutic interventions to treat inflammatory skin diseases.
To understand whether we can modulate inflammation-induced chromatin rearrangements either positively to augment wound healing or negatively to wipe clean
a slate of inflammatory exposures that potentially contribute to disease pathogenesis, we need to have a better understanding of the underlying mechanisms. How is
inflammatory memory established and why do only a small subset of domains re-
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main primed? To this end, our genomic approaches have identified unique features
of the memory chromatin domains namely the unique retention of H3K4me1. Probing
for deposition and maintenance of these marks will elucidate how select chromatin
domains remain accessible.
All together, this work highlights EpSCs commitment to maintaining tissue integrity. Their ability to respond to inflammatory stress and retain rapid response chromatin domains make EpSCs formidable masons that generate and maintain the skin
barrier.
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CHAPTER 5

MATERIALS AND METHODS

Animals
The following mouse strains were purchased from the Jackson Laboratories: C57BL/6,
B6.FVB-Tg(Rorc-Cre)1Litt/J (Rorc-Cre), C57BL/6-Gt(ROSA), 26Sortm1(HBEGF)Awai/J
B6-Rosa26iDTR, B6.129P2-Aim2Gt(CSG445)Byg/J, B6.129S7-Il1r1tm1Imx/J, and
B6.129P2-Il18tm1Aki/J. Tg(Rorc-EGFPEbemice were a gift from Dr. Gerard Eberl
(Institut Pasteur). Tg(Ly6a-Cre)1Isg mice were a gift from Dr. Isidro Sanchez-Garcia
(Universidad de Salamanca). Krt14CreER and Krt14rtTA mice were previously generated in the Fuchs’ lab. Krt10CreER transgenic mice were generated by retrieving the murine Krt10 promoter region (8416 bp fragment upstream of Krt10 start
codon) from bacterial articial chromatin DNA (CHORI clone ID:RP23-336D20) and
then inserting it upstream of the Beta-Globin Intron-CreER–polyA, analogous to our
Krt14CreER transgene. All keratin promoter driven CreER mice were then each
crossed to Rosa26Flox-Stop-Flox-YFP mice. Mice were bred and maintained under
pathogen-free conditions at an American Association for the Accreditation of Laboratory Animal Care (AAALAC)-accredited animal facility at the Rockefeller University
and housed in accordance with the procedures outlined in the Guide for the Care and
Use of Laboratory Animals. When possible, preliminary experiments were performed
to determine requirements for sample size, taking into account resources available
and ethical, reductionist animal use. Animal studies were not performed in a blinded
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fashion. Animals were assigned randomly to experimental groups.
Skin inflammation models
The dorsal skin of 8 week old mice in the telogen (resting) phase of the hair cycle
were shaved with clippers and then subjected to topical application or treatment of
the skin as below:
Imiquimod: Mice were treated with either 1 mg/cm2 skin of 5% imiquimod cream
(Perrigo) or control Vanicream (Pharmaceutical Specialties Inc.) for six consecutive
days as previously described.
Epidermal abrasion wounds: Mice were treated with depilatory agent Nair (Church
and Dwight). A 2 cm2 area was then wounded shallowly with a rotary drill (Model 520
Dremel) as previously described to remove the epidermis and induce re-epithelialization
of the wounded skin.
TPA: Mice were topically treated with 40 nM/3cm2 skin 12-O-tetradecanoylphorbol
13-acetate (TPA) (Sigma-Aldrich) in acetone or acetone alone daily for five consecutive days.
MC903: Mice were topically treated with 2 nM/3cm2 skin of vitamin D analog
Calcipotriol (MC903) (Tocris Bioscience) in EtOH or EtOH alone for 14 consecutive
days as previously described.
Candida albicans (Fungi) infection: Mice were infected with 106 Candida albicans
(ATCC36801) as previously described.
Lineage tracing
At 8 weeks of age during the telogen (resting) phase of the hair cycle, mice were
treated with 10 µ/ml of 4-hydroxytamoxifen (TAM) in corn oil (Sigma-Aldrich) by intraperitoneal (i.p.) injection for 3 consecutive days at the following doses: Krt14CreER;RosaYFP
treated with 10 µg of TAM, and K10CreER;RosaYFP treated with 100 µg of TAM. Two
days after the last tamoxifen treatment, the dorsal skin of a cohort of mice was analyzed for YFP expression by flow cytometry and immunofluorescence (Day 0 time
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point). Upon confirmation of YFP expression the remaining cohort mice were treated
with the aforementioned IMQ regimen and analyzed at days 6, 30, and 180 posttreatment.
EdU pulse
For 5’-ethynyl-2’-deoxyuridine (EdU) pulse experiments, mice were injected intraperitoneally (50 µg/g) (Sigma-Aldrich) at specified intervals (typically 1-4 hrs) before analysis.
Punch biopsy and splint wounds
The dorsal skin of mice was shaved at indicated time points after imiquimod treatment. After visually confirming that hair follicles in the shaved area were in telogen
(resting) phase of the hair cycle, 6 mm biopsy punches (Miltex) were used to make
full-thickness wounds. Wound closure was assessed macroscopically with an engineer’s caliper daily. 3 mm wounds were splinted with 8 mm silicone splints as previously described. Wound closure was assessed macroscopically with an engineer’s
caliper daily. Wound area was calculated by applying the area of an ellipse (π*r1*r2)
to the two diameter measurements on the y-axis, and x-axis of the wound. One-, twoand three-phase decay model of curve fitting was performed for wound healing assays. The two- and three-phase decay analyses showed minimal contributions from
second (Kslow Ctrl=0.00015 PI=0.0017) phase and generated an “ambiguous fit” error indicating wide confidence intervals and that the software (PRISM GraphPad) is
unable to find a unique curve to fit the data. Therefore, wound healing rate constants
were calculated using a One-Phase Decay Model (PRISM GraphPad).
Diptheria toxin administration
Mice were intraperitonially (i.p.) injected with 200 ng of Diptheria Toxin (Sigma
Aldrich) twice daily for 5 consecutive days. Mice were maintained on a sulfatrim
diet and 0.5 mg/ml oral fluconazole (Citron Pharma) supplemented in drinking water
throughout the course of treatment and subsequent wounding experiment.
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Caspase inhibitor administration
Mice were i.p. injected with 0.6 mM of Ac-YVAD-cmk (Caymon Chemicals) 1 day
prior to wounding and then daily for the first five days of the wound response.
Clodronate liposome administration
Mice were i.p. injected with either 200 µl clodronate or control liposomes 8 days
prior to and then every two days until wounding.
Anti-IL1R1 administration
Mice were i.p. injected with 0.2 µg of Anti-IL1R1 antibody (JAMA-147) or Armenian Hamster Isotype control (BioXCell) 1 day prior to wounding and then daily for the
first five days of the wound response.
In utero lentiviral (LV) transduction
Transductions were achieved by in utero injection of lentivirus into the amniotic
sacs of E9.5 mice. At E9.5, the surface ectoderm exists as a single layer of unspecified Krt14+ EpSC progenitors, which become stably transduced by LV within 24 hrs.
High LV titers enable highly efficient and selective transduction of the entire embryonic
skin epithelium, without affecting other skin cell types. In utero injections are noninvasive and do not alter embryonic development or elicit inflammatory responses in
the skin. The DNA carried by the lentivirus is stably propagated into adulthood within
the skin epithelium, including the epidermis and hair follicles. In utero LV deliveries
were used for all ATAC-peak reporters and for delivery of TRE-Aim2 expression.
Doxycycline Feed Administration
Mice transduced with LV-TRE-Aim2 were placed on 2 mg/kg doxycycline feed
(Bioserv) at postnatal day 53 and maintained on doxycycline diet throughout the
course of wound repair.
Cell Isolation and Tissue Processing
Keratinocyte isolation was adapted from a previously described protocol. Briefly,
dorsal skin was shaved and digested using either 0.25% Trypsin/EDTA (Gibco) or
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Collagenase (Sigma) to obtain a single cell suspension. Immune cells from 1 cm+
pieces of skin were isoplated after digestion with Liberase TM (Roche) based on an
adapted procol. To isolate wound edge epithelial stem cells, 0.5 mm2 of skin adjacent
to the wound was excised and digested in collagenase.
Ex vivo explant migration assay
The ex vivo explant migration assay was performed as previously described. 2 mm
punch biopsies (Miltex) were taken from the back skin after hair depilation. The skin
was adhered to the bottom of a fibronectin-coated plate with matrigel (Corning) and
cultured in 300 µM Ca2+ keratinocyte growth media made as previously described.
Explants supplemented with recombinant IL-18 and IL-1β (Peprotech) received 50
ng/ml of the cytokine daily. Outgrowth of Krt14+ cells from explants was imaged at
indicated time-points using the 10X objective of a Nikon Eclipse TS100 microscope
equipped with an Exfo X-Cite Series 120 and a Hamamatsu ORCA-ER Digital Camera. Images were analyzed with ImageJ software.
Flow cytometry and cell sorting
Female mice were used for sorting experiments at all time points and conditions
to obtain maximal cell numbers. Single cell suspensions were stained with antibodies (Extended Data Table 1) at predetermined concentrations in a 100 µl staining
buffer (PBS containing 5%FBS and 1% HEPES) per 106 cells. Stained cells were resuspended in 4’,6-diamidino-2-phenylindole (DAPI) in FACS buffer (Sigma-Aldrich)
prior to analysis. Data were acquired on LSRII Analyzers (BD Biosciences) and then
analyzed with FlowJo program. Fluorescence-activated cell sorting (FACS) was conducted using Aria Cell Sorters (BD Biosciences) into either staining buffer or Trizol LS
(Invitrogen).
Immunofluorescence and image analysis
Immunofluorescence staining protocols were adapted from [22]. Briefly tissue
was fixed in 4% paraformaldehyde in PBS for 20 min at room temperature or 4 hours
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at 4◦ C. Tissue was washed 3X with PBS and switched to 20% sucrose overnight
and subsequently washed. Tissue was then embedded in OCT (Tissue Tek), frozen,
cryosectioned (14-20 µm). Sections were permeabilized, blocked and stained with
primary and then secondary fluorescence conjugated antibody. Nuclei were stained
using 4’6’-diamidino-2-phenylindole (DAPI). EdU and TUNEL Click-It reaction were
performed according to manufacturer’s directions (Life Technologies). For pSTAT3
immunofluorescence, sections were fixed in methanol for 20 minutes at -20◦ C before primary and secondary antibody labeling. For complete list of antibodies see
Extended Data Table 2. Migrating tongue was determined by measuring the length
of Keratin14+ Integrin-α5+ cells. Percentage of wound-edge proliferating EpSCs was
determined by counting EdU+ Keratin14+ cells per total number of Keratin17+ cells.
Data were analyzed using ImageJ Software.
Confocal microscopy and image processing
Images were acquired with an AxioOberver.Z1 epifluorescence microscope equipped
with a Hamamatsu ORCA-ER camera and an ApoTome.2 (Carl Zeiss) slider. Tiled
and stitched images of sagittal sections were collected using a 20X or 40X objective,
controlled by Zen software (Carl Zeiss). Maximal projection Z-stacks are presented
and co-localizations were interpreted only in single Z-stacks. Z-stacks were projected
using ImageJ software. RGB images were assembled in Adobe Illustrator CC2015.3.
Histology
Skin tissue was fixed in PBS containing 10% formalin, paraffin embedded, sectioned (0.8 mm) and stained with hematoxylin and eosin by Histowiz Inc. Stained
slides were scanned at 40X magnification using Aperio AT2. Slides were visualized
and epidermal thickness was analyzed using Aperio Image Scope software.
Gross images
Animals were imaged using a Leica DFC310 FX fitted with a Schott Fostec Ace
fiber optic light source and a Leica microscope video lens objective 0.63x no. 10447367.
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RNA purification, quantitative PCR and RNA-sequencing
Quantitative PCR: Individual animals were used for qPCR experiments. Total RNA
was purified from either whole skin biopsies, flash frozen and then homogenized with
a Bessman Tissue Pulverizer (SpectrumTM) or FACS purified keratinocyte populations using Direct-zol RNA MiniPrep kit (Zymo Research) per manufacturer’s instructions. Equal amounts of RNA were reverse-transcribed using the superscript VILO
cDNA synthesis kit (Invitrogen). cDNAs for each sample were normalized to equal
amounts using primers against Actb. XpressRef Universal Total RNA (Qiagen) was
used as a negative control to assess FACS population purity. For complete list of
qPCR primers refer to Data Table 1.
RNA-seq: 3-4 animals were pooled per condition for each RNA-seq experiment.
Total RNA was isolated from FACS purified keratinocyte populations using Direct-zol
RNA MiniPrep kit (Zymo Research) per manufacturer’s instructions. Quality of the
RNA for sequencing was determined using Agilent 2100 Bioanalyzer, all samples
used had RNA integrin numbers (RIN) 9. Poly-A selection and library preparation
using Illumina TrueSeq mRNA sample preparation kit and sequencing on Illumina
HiSeq 2500 or HiSeq 4000 machines was performed by Weill Cornell Medical College
Genomic Core facility, 50 bp Single-end FASTQ sequences were aligned to mouse
genome (GRCm38/mm10) using STAR41 and transcripts were annotated using Gencode release M9. Differential gene expression analysis was performed using DESeq2
package using the gene counts output from STAR read aligner.
Ingenuity pathways analyses were performed on differentially expressed genes 12
hours post-wounding.
ATAC-Seq
Assay was performed on 100K FACS purified cells as previously described. Briefly,
cells were lysed in ATAC lysis buffer for 5 minutes and then transposed with TN5
transposase (Illumina) for 30 minutes. Samples were barcoded and sequencing li-
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Table 5.1: qPCR Primer List
Gene Name
β-actin
Aim2
H2-M2
Trp63
Klf5
Lhx2
Cd34
Sox10
Pdgfra
Ptprc(CD45)
Vcam1

Forward Primer
ccaaccgtgaaaagatgacc
caggcaattgcatctgagag
tgtactttcagaaactgcgagact
cactctccatgccctcca
gattcacaacccaaatttacctg
cagcttgcgcaaaagacc
gaaccgtcgcagttggag
atgtcagatgggaacccaga
aagacctgggcaagaggaac
ttcagaaaatgcaacagtgaca
tggtgaaatggaatctgaacc

Reverse Primer
accagaggcatacgggaca
cgcctcacaaagattttcact
tcatcctttggatggtgtga
gcccaaccttgctaagaaact
ctttgtataaacttttgtgcaacca
taaaaggttgcgcctgaact
tccaccattctccgtgtaataa
gtgtttggggtggttggag
gaacctgtctcgatggcact
ccaactgacatctttcaggtatga
gacccagatggtggtttcc

brary was prepared according to manufacturer’s guidelines (Illumina) and sequenced
on an Illumina HiSeq 2500.
For sequencing data analysis 50 bp paired-end FASTQs were aligned to mouse
genome (GRCm38/mm10) as previously described. Correlation between replicates
was measured by first calling peaks in each replicate, merging the peak sets, followed
by plotting Log2 transformed signal against individual replicates. Aligned reads for the
two replicates were then merged and peaks called on the merged dataset. Genomic
annotation of peaks was performed using the Cis-regulatory Element Annotation System (CEAS).
Average ATAC signals for transcription start sites (TSS, +/- 3000 bp) and for chromatin insulator protein CTCF sites (+/- 1000 bp) were plotted for each sample CTCF
sites were derived from CTCF peaks called in E14.5 C57BL/6 limb embryo from
ENCODE (Accession: ENCFF001YAK) and converted to mm10 coordinates using
liftOver. Average tag count is calculated by averaging the number of reads overlapping each base pair per million mapped reads. (Number of reads at each base
pair)/(Total readcounts x106 ). X-axis is distance from either the CTCF of TSS site.
ATAC-Seq peaks were determined algorithmically using Model-based Analysis of
ChIP-Seq 2 (MACS2) algorithm with the option “–keep-dup all” to keep duplicates

76

generated by combining experimental replicates. Each peak is of varying size representing regions of signal enrichment over background. Shared peaks were defined
as regions that had 1base pair overlap between the two datasets. Unique peaks
were then defined as regions that had no overlap. Regions where signal intensity did
not meet the threshold (FDR 0.01) for statistical significance over background were
considered “closed”.
Z-score transformations were performed to normalize data across various samples and time points. ATAC signals per base-pair over the mouse genome (GRCm38/mm10),
excluding the mitochondrial and Y chromosome, were scored and then averaged over
500 bp non-overlapping genomic windows. Background signal was then filtered out
by excluding genomic windows that averaged less than 1 in any replicates. Data was
clustered using Cluster 3.0 and visualized using GENE-E software46. Significantly
different windows were assayed between samples by t-test (p-value 0.05).
Sequencing data tracks were presented using University of California Santa Cruz
genome browser. Unique peaks at from day 6 and day 30 control and IMQ treated
EpSCs, and overlapping peaking from day 6 and day 30 IMQ treated EpSCs were
subject to ontology analysis using Genomic Regions Enrichment of Annotation Tool
(GREAT) with whole mouse genome (GRCm38/mm10) as the background. PANTHER pathways analysis was used to compare peak-associated genes with known
pathways. Motif analysis of these regions was performed using HOMER software.
Selected ontologies and MOTIFS are displayed. Values below the false positive range
(1e-10 to 1e-12) for this algorithm were considered statistically significant.
Peak reporters
Genomic regions with enriched signal in post-inflamed EpSCs associated with
Aim2 (Peak1 - Chr1:173,420,163-173,420,883, Peak 2 - Chr1:173,422,670-173,423,721)
Armc6 (Chr8:70,221,668-70,222,912), Aoah (Chr13:20,935,623-20,936,830), and Cotl1
(Chr8:119,810,704-119,812,768) were PCR amplified from keratinocyte genomic DNA
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and cloned into a pLKO-PGK-H2B-mRFP1-“Peak”-minSV40-EGFP vector. After sequence verification individual plasmids were packaged into a lentivirus injected in
utero into the amniotic sacs of E9.5 C57BL/6 embryos, as described above.
Inducible Aim2 mice
Murine Aim2 cDNA was amplified from FACS purified EpSCs and cloned downstream of the TRE and minimal promoter of the pLKO-TRE-PGK-H2BmRFP1 vector.After sequence verification the plasmid was packaged into a lentivirus for in utero
injection into the amniotic sac of K14rtTA E9.5 embryos. Aim2 induction was verified
by qPCR 7 days after doxycycline administration to activate rtTA, which in turn binds
to the TRE element.
CASPASE 1 fluorometric and cytokine enzyme-linked immunosorbent assay
(ELISAs)
Tissue lysates from 0.5 mm2 wound edge skin 12 hours post-injury were prepared
by freeze thawing and then dissociating tissue with a tissue lyser (Qiagen). Lysates
were assayed for CASP1 activity and cytokine levels. CASPASE-1/ICE flourometric assay (RD) and IL-1β (eBioscience) and IL-18 (MBL international) ELISAs were
performed according to manufacturer’s instructions. Recombinant human CASP1
(Sigma-Aldrich) was used a standard to determine CASP1 activity. All assays were
normalized to total protein levels in lysate as measured by PierceTM BCA Protein
Assay Kit (ThermoFisher).
Two-step carniogenesis model
Topical 7,12-Dimebthylbenz(a)anthracene (DMBA)/ 12-O-Tetradecanoylphorbo-13acetate (TPA) was performed as previously described [98]. Briefly, the back skin of
post-inflamed or inflammation naive mice (P90) was shaved and treated with 400 nM
DMBA in 100 µl acetone. Thereafter mice were treated with 17 nM TPA in 100 µl acetone twice weekly for the duration of the experiment. Tumors were measured weekly
with an engineer’s caliper.
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GPower software was used to determine the achieved power of the study. Using
the observed mean and standard deviation of each group, the observed effect size
was calculated. With 3 mice in each group and setting the desired significance level
to 0.05, the software can determine the power achieved.
Multiplexed indexed T7 ChIP-seq (MINT-ChIP)
200K EpSCs from each condition were collected from 2-3 mice as previously described. Cells were split into 2 groups (100K each) low MNase (to capture large fragments) and high Mnase (to capture small fragments). After digestion each sample
received an individual T7 adapter, after which each sample was pooled and divided
into groups based on histone antibody ChIP (either Total H3, H3K27ac, H3K4me1,
or H3K27me3). After immunoprecipitation each ChIP received an Illumina barcode.
Samples could then be pooled together in equal concentration and submitted for sequencing. Replicates 2 and 3 were sequenced on the Illumina HiSeq 2500. Replicate
1 was sequenced on Illumina NextSeq 4000. All sequencing was paired-end.
Data processing was done in accordance with the methods outlined by Bradley
Bernstein’s group [99]. Briefly, files were de-multiplexed using bcl2fastq algorithms.
Read1 was demuliplexed further based on the T7-adapter barcode (first 6 bases of
the read). Glimpse package allowed for 1 mismatch. Corresponding reads based on
the identifier were extracted from Read2 fastq files, and the files trimmed to remove
the barcodes. Burrows-Wheeler Aligner was used for paired-end alignment to mm10
genome.
Resulting bam files were then filtered in three stages to: remove multimapped and
unmapped reads, PCR duplicates (using Picard Tools option MarkDuplicates), and
T7 duplicates (have identical Read1 but variable Read2). Filtered bam files could
be views as tiled data files in IGV and peaks were called using the Homer package.
Pos2bed.pl and bedtools merge were used to generate bed files. Quantitative normalization was achieved by dividing the peak signal values by the number of Total H3

79

reads in the corresponding data set.
Data processing for this data set was performed by Thomas Carroll, and I would
again like to thank him for the tremendous help he has provided.
Statistics
Data are presented as mean standard error of the mean, mean ± standard deviation, or mean ± 95% confidence interval. Group sizes were determined based
on the results of preliminary experiments. Mice were assigned at random to groups.
Experiments were not performed in a blinded fashion. Statistical significance was determined with the two-tailed unpaired Student’s t-test, under the untested assumption
of normality. Within each group there was an estimate of variation, and the variance
between groups was similar. Statistical significance of ATAC-seq peak gene comparisons was calculated using a Mann-Whitney test). Statistical analysis was calculated
using either Prism software (GraphPad), DESeq2 or in R.
Data availability
Datasets generated and/or analyzed during the current study are presented in
the published article [74] or the accompanying Source Data or Supplementary Information files. Genomic datasets generated during and/or analyzed during the current
study are available in the Gene Expression Omnbibus (GEO) repository under accession GSE92967. AI2KO ATAC-Seq and MINT ChIP data sets will be released upon
publication.
Antibodies
Table 5.2: Antibody List
Begin of Table 5.2
Antibody

Source

Identifier

Chicken Anti-Mouse GFP

Abcam

Cat ab13970

Rabbit Anti-Mouse Keratin 14

Fuchs Lab

N/A

Rabbit Anti-Mouse Keratin 10

Fuchs Lab

N/A
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Continuation of Table 5.2
Antibody

Source

Identifier

Rabbit Anti-Mouse Keratin 24

Fuchs Lab

N/A

Rat Anti-Mouse CD49e (integrin-a5)

BD Pharmingen

Cat 553319

Rat Anti-Mouse CD3e clone: 17A2

Biolegend

Cat 100212

Armenian

Anti-Mouse

Biolegend

Cat 1181011

Armenian Hamster Anti-Mouse TCRb

Biolegend

Cat 109227

Biolegend

Cat 118133

eBiosciences

Cat 45-0242-80

Biolegend

Cat 101223

Biolegend

Cat 139307

Biolegend

Cat 107625

BD Pharmingen

Cat 552128

Anti-Mouse Ly6c-FITC Clone: HK1.4

Biolegend

Cat 128005

Anti-Mouse CD34 eFluor 660 Clone:

eBiosciences

Cat 50-0341-82

clone: 5H10-27

Hamster

gdTCR clone: GL3

Clone: H57-597 PerCp/Cy5.5
Armenian

Hamster

Anti-Mouse

gdTCR clone: GL3 AF647
Anti-Mouse CD24 Clone:

M1/69

PerCP/Cy5.5
Anti-Mouse CD11b-PacBlue Clone:
M1/70
Anti-Mouse CD64-PerCP-Cy5 Clone:
X54-5/7.1
Anti-Mouse

CD11c-PECy7Clone:

N418 Biolegend Cat 117317
Anti-Mouse

I-A/I-E

(MHCII)

PerCp/Cy5.5 Clone: 107625
Rat Anti-Mouse Siglec-F Clone: E502440 PE

RAM34
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Continuation of Table 5.2
Antibody

Source

Identifier

Anti-Mouse Ly-6A/E (Sca-1) Clone

Biolegend

Cat 108126

Biolegend

Cat 313602

eBiosciences

Cat 12-0495-81

Biolegend

Cat 103116

Biolegend

Cat 103104

Biolegend

Cat 105804

Biolegend

Cat 135910

Biotin Anti-Mouse CD31 Clone: 390

Biolegend

Cat 102404

Rabbit Anti-pStat3 (Tyr705) Clone:

Cell Signaling

Cat 9145

Biolegend

Cat 102214

Biolegend

Cat 102201

Active Motif

39763

Anti-Mouse H3K27ac (for ChIP)

Active Motif

39133

Anti-Mouse H3K27ac (for Western)

Abcam

ab4729

D7 APC/Cy7
Purified Anti-Human/Mouse CD49f
Clone: GoH3
Anti Human/Mouse Cd49f PE Clone:
GoH3
APC/Cy7 Anti-Mouse CD45 Clone:
30-F11
Biotin Anti-Mouse CD45 Clone: 30F11
Biotin Anti Mouse CD117 (c-kit)
Clone: 2B8
Biotin Anti-Mouse CD140a Clone:
APA5

D3A7
Anti-Mouse/Rat CD29 Clone: HMB11
Purified Anti-Mouse/Rat CD29 Clone:
HMB1-1
Anti-Mouse Total H3 Clone:

MABI

0301
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Continuation of Table 5.2
Antibody

Source

Identifier

Anti-Mouse H3K27me3

Abcam

ab6002

Anti-Mouse H3K4me1 Clone: D1A9

Cell Signaling

5326S

FITC Streptavidin

Biolegend

Cat 405202

Donkey Anti-Rabbit AF488 conju-

Jackson

gated secondary

munoResearch

Donkey Anti-Rabbit AF546, conju-

Jackson

gated secondary

munoResearch

Donkey Anti-Rabbit AF647, conju-

Jackson

gated secondary

munoResearch

Donkey Anti-Rat AF488, conjugated

Jackson

secondary

munoResearch

Donkey Anti-Rat AF647, conjugated

Jackson

secondary

munoResearch

DyLight 594 Goat Anti-Ar. Hamster

Biolegend

XP

AF594 Clone: Poly4055

End of Table
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Im-

Im-

Im-

Im-

Im-

Cat 711-545-152

Cat 711-165-152

Cat 711-605-152

Cat 712-545-150

Cat 712-605-150

Cat 405504
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